WO2012010918A2 - Optical devices - Google Patents
Optical devices Download PDFInfo
- Publication number
- WO2012010918A2 WO2012010918A2 PCT/HU2011/000077 HU2011000077W WO2012010918A2 WO 2012010918 A2 WO2012010918 A2 WO 2012010918A2 HU 2011000077 W HU2011000077 W HU 2011000077W WO 2012010918 A2 WO2012010918 A2 WO 2012010918A2
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- general formula
- group
- same
- alkyl
- benzoyloxy
- Prior art date
Links
- 230000003287 optical effect Effects 0.000 title abstract description 12
- 239000000178 monomer Substances 0.000 claims abstract description 26
- 229920000642 polymer Polymers 0.000 claims abstract description 23
- -1 hydroxyalkyl acrylates Chemical class 0.000 claims abstract description 22
- 125000003118 aryl group Chemical group 0.000 claims abstract description 10
- 238000004519 manufacturing process Methods 0.000 claims abstract description 4
- 150000001875 compounds Chemical class 0.000 claims description 53
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 claims description 45
- 238000000034 method Methods 0.000 claims description 39
- 238000002360 preparation method Methods 0.000 claims description 30
- ZMANZCXQSJIPKH-UHFFFAOYSA-N Triethylamine Chemical compound CCN(CC)CC ZMANZCXQSJIPKH-UHFFFAOYSA-N 0.000 claims description 28
- DBCAQXHNJOFNGC-UHFFFAOYSA-N 4-bromo-1,1,1-trifluorobutane Chemical compound FC(F)(F)CCCBr DBCAQXHNJOFNGC-UHFFFAOYSA-N 0.000 claims description 20
- STVZJERGLQHEKB-UHFFFAOYSA-N ethylene glycol dimethacrylate Substances CC(=C)C(=O)OCCOC(=O)C(C)=C STVZJERGLQHEKB-UHFFFAOYSA-N 0.000 claims description 20
- 238000006243 chemical reaction Methods 0.000 claims description 19
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 claims description 15
- 125000000217 alkyl group Chemical group 0.000 claims description 15
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 claims description 15
- 239000002904 solvent Substances 0.000 claims description 15
- 125000005843 halogen group Chemical group 0.000 claims description 14
- 125000004435 hydrogen atom Chemical group [H]* 0.000 claims description 14
- 239000000463 material Substances 0.000 claims description 11
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 claims description 11
- UNRDNFBAJALSEY-UHFFFAOYSA-N 2-prop-2-enoyloxyethyl benzoate Chemical compound C=CC(=O)OCCOC(=O)C1=CC=CC=C1 UNRDNFBAJALSEY-UHFFFAOYSA-N 0.000 claims description 10
- 125000004432 carbon atom Chemical group C* 0.000 claims description 10
- 125000002887 hydroxy group Chemical group [H]O* 0.000 claims description 10
- 125000003545 alkoxy group Chemical group 0.000 claims description 9
- 239000003431 cross linking reagent Substances 0.000 claims description 9
- WKBOTKDWSSQWDR-UHFFFAOYSA-N Bromine atom Chemical compound [Br] WKBOTKDWSSQWDR-UHFFFAOYSA-N 0.000 claims description 8
- ZAMOUSCENKQFHK-UHFFFAOYSA-N Chlorine atom Chemical compound [Cl] ZAMOUSCENKQFHK-UHFFFAOYSA-N 0.000 claims description 8
- PXGOKWXKJXAPGV-UHFFFAOYSA-N Fluorine Chemical compound FF PXGOKWXKJXAPGV-UHFFFAOYSA-N 0.000 claims description 8
- GDTBXPJZTBHREO-UHFFFAOYSA-N bromine Substances BrBr GDTBXPJZTBHREO-UHFFFAOYSA-N 0.000 claims description 8
- 229910052794 bromium Inorganic materials 0.000 claims description 8
- 229910052801 chlorine Inorganic materials 0.000 claims description 8
- 239000000460 chlorine Substances 0.000 claims description 8
- 229910052731 fluorine Inorganic materials 0.000 claims description 8
- 239000011737 fluorine Substances 0.000 claims description 8
- 125000000168 pyrrolyl group Chemical group 0.000 claims description 8
- 125000001424 substituent group Chemical group 0.000 claims description 8
- 125000002541 furyl group Chemical group 0.000 claims description 7
- IRUHNBOMXBGOGR-UHFFFAOYSA-N 2-(2-methylprop-2-enoyloxy)ethyl benzoate Chemical compound CC(=C)C(=O)OCCOC(=O)C1=CC=CC=C1 IRUHNBOMXBGOGR-UHFFFAOYSA-N 0.000 claims description 6
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 claims description 6
- NIXOWILDQLNWCW-UHFFFAOYSA-N acrylic acid group Chemical group C(C=C)(=O)O NIXOWILDQLNWCW-UHFFFAOYSA-N 0.000 claims description 6
- SNVLJLYUUXKWOJ-UHFFFAOYSA-N methylidenecarbene Chemical compound C=[C] SNVLJLYUUXKWOJ-UHFFFAOYSA-N 0.000 claims description 6
- 125000001544 thienyl group Chemical group 0.000 claims description 6
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 claims description 5
- 125000004453 alkoxycarbonyl group Chemical group 0.000 claims description 5
- 239000011230 binding agent Substances 0.000 claims description 5
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 claims description 5
- 229910052739 hydrogen Inorganic materials 0.000 claims description 5
- 239000001257 hydrogen Substances 0.000 claims description 5
- 125000001624 naphthyl group Chemical group 0.000 claims description 5
- 125000000449 nitro group Chemical group [O-][N+](*)=O 0.000 claims description 5
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 claims description 5
- 230000002209 hydrophobic effect Effects 0.000 claims description 4
- 239000007858 starting material Substances 0.000 claims description 4
- 239000002253 acid Substances 0.000 claims description 3
- 125000005397 methacrylic acid ester group Chemical group 0.000 claims description 3
- HSOOIVBINKDISP-UHFFFAOYSA-N 1-(2-methylprop-2-enoyloxy)butyl 2-methylprop-2-enoate Chemical compound CC(=C)C(=O)OC(CCC)OC(=O)C(C)=C HSOOIVBINKDISP-UHFFFAOYSA-N 0.000 claims description 2
- ZCYVEMRRCGMTRW-UHFFFAOYSA-N 7553-56-2 Chemical compound [I] ZCYVEMRRCGMTRW-UHFFFAOYSA-N 0.000 claims description 2
- PNDPGZBMCMUPRI-UHFFFAOYSA-N iodine Chemical compound II PNDPGZBMCMUPRI-UHFFFAOYSA-N 0.000 claims description 2
- 239000011630 iodine Substances 0.000 claims description 2
- 229910052740 iodine Inorganic materials 0.000 claims description 2
- 239000003960 organic solvent Substances 0.000 claims description 2
- 125000002915 carbonyl group Chemical group [*:2]C([*:1])=O 0.000 abstract description 3
- 150000002734 metacrylic acid derivatives Chemical class 0.000 abstract description 3
- 229920002100 high-refractive-index polymer Polymers 0.000 abstract description 2
- QIGBRXMKCJKVMJ-UHFFFAOYSA-N Hydroquinone Chemical compound OC1=CC=C(O)C=C1 QIGBRXMKCJKVMJ-UHFFFAOYSA-N 0.000 description 22
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 17
- 239000000047 product Substances 0.000 description 16
- UXVMQQNJUSDDNG-UHFFFAOYSA-L Calcium chloride Chemical compound [Cl-].[Cl-].[Ca+2] UXVMQQNJUSDDNG-UHFFFAOYSA-L 0.000 description 15
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 14
- 229920001577 copolymer Polymers 0.000 description 13
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 13
- 239000001110 calcium chloride Substances 0.000 description 12
- 229910001628 calcium chloride Inorganic materials 0.000 description 12
- 239000012074 organic phase Substances 0.000 description 11
- 239000011541 reaction mixture Substances 0.000 description 11
- 239000003999 initiator Substances 0.000 description 10
- 238000010992 reflux Methods 0.000 description 9
- ZMXDDKWLCZADIW-UHFFFAOYSA-N N,N-Dimethylformamide Chemical compound CN(C)C=O ZMXDDKWLCZADIW-UHFFFAOYSA-N 0.000 description 8
- PASDCCFISLVPSO-UHFFFAOYSA-N benzoyl chloride Chemical compound ClC(=O)C1=CC=CC=C1 PASDCCFISLVPSO-UHFFFAOYSA-N 0.000 description 8
- 229910052757 nitrogen Inorganic materials 0.000 description 8
- 239000012071 phase Substances 0.000 description 7
- OMIGHNLMNHATMP-UHFFFAOYSA-N 2-hydroxyethyl prop-2-enoate Chemical compound OCCOC(=O)C=C OMIGHNLMNHATMP-UHFFFAOYSA-N 0.000 description 6
- LYCAIKOWRPUZTN-UHFFFAOYSA-N Ethylene glycol Chemical compound OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 description 6
- KWYUFKZDYYNOTN-UHFFFAOYSA-M Potassium hydroxide Chemical compound [OH-].[K+] KWYUFKZDYYNOTN-UHFFFAOYSA-M 0.000 description 6
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 6
- 239000000203 mixture Substances 0.000 description 6
- NIXOWILDQLNWCW-UHFFFAOYSA-M Acrylate Chemical compound [O-]C(=O)C=C NIXOWILDQLNWCW-UHFFFAOYSA-M 0.000 description 5
- 230000007935 neutral effect Effects 0.000 description 5
- XFDQLDNQZFOAFK-UHFFFAOYSA-N 2-benzoyloxyethyl benzoate Chemical compound C=1C=CC=CC=1C(=O)OCCOC(=O)C1=CC=CC=C1 XFDQLDNQZFOAFK-UHFFFAOYSA-N 0.000 description 4
- WRMNZCZEMHIOCP-UHFFFAOYSA-N 2-phenylethanol Chemical compound OCCC1=CC=CC=C1 WRMNZCZEMHIOCP-UHFFFAOYSA-N 0.000 description 4
- ILZXXGLGJZQLTR-UHFFFAOYSA-N 2-phenylethyl 2-methylprop-2-enoate Chemical compound CC(=C)C(=O)OCCC1=CC=CC=C1 ILZXXGLGJZQLTR-UHFFFAOYSA-N 0.000 description 4
- CERQOIWHTDAKMF-UHFFFAOYSA-M Methacrylate Chemical compound CC(=C)C([O-])=O CERQOIWHTDAKMF-UHFFFAOYSA-M 0.000 description 4
- 125000005250 alkyl acrylate group Chemical group 0.000 description 4
- 238000001816 cooling Methods 0.000 description 4
- 239000002994 raw material Substances 0.000 description 4
- SMZOUWXMTYCWNB-UHFFFAOYSA-N 2-(2-methoxy-5-methylphenyl)ethanamine Chemical compound COC1=CC=C(C)C=C1CCN SMZOUWXMTYCWNB-UHFFFAOYSA-N 0.000 description 3
- LSWRBVSEWBWTDR-UHFFFAOYSA-N 2-hydroxyethyl benzoate Chemical compound OCCOC(=O)C1=CC=CC=C1 LSWRBVSEWBWTDR-UHFFFAOYSA-N 0.000 description 3
- WOBHKFSMXKNTIM-UHFFFAOYSA-N Hydroxyethyl methacrylate Chemical compound CC(=C)C(=O)OCCO WOBHKFSMXKNTIM-UHFFFAOYSA-N 0.000 description 3
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 3
- 125000004423 acyloxy group Chemical group 0.000 description 3
- 239000000654 additive Substances 0.000 description 3
- 239000012965 benzophenone Substances 0.000 description 3
- CQEYYJKEWSMYFG-UHFFFAOYSA-N butyl acrylate Chemical compound CCCCOC(=O)C=C CQEYYJKEWSMYFG-UHFFFAOYSA-N 0.000 description 3
- 239000012153 distilled water Substances 0.000 description 3
- 238000003754 machining Methods 0.000 description 3
- 238000006116 polymerization reaction Methods 0.000 description 3
- 238000001556 precipitation Methods 0.000 description 3
- 150000003839 salts Chemical class 0.000 description 3
- 238000000926 separation method Methods 0.000 description 3
- 239000003381 stabilizer Substances 0.000 description 3
- 238000003756 stirring Methods 0.000 description 3
- ILWRPSCZWQJDMK-UHFFFAOYSA-N triethylazanium;chloride Chemical compound Cl.CCN(CC)CC ILWRPSCZWQJDMK-UHFFFAOYSA-N 0.000 description 3
- 238000005160 1H NMR spectroscopy Methods 0.000 description 2
- VZSRBBMJRBPUNF-UHFFFAOYSA-N 2-(2,3-dihydro-1H-inden-2-ylamino)-N-[3-oxo-3-(2,4,6,7-tetrahydrotriazolo[4,5-c]pyridin-5-yl)propyl]pyrimidine-5-carboxamide Chemical compound C1C(CC2=CC=CC=C12)NC1=NC=C(C=N1)C(=O)NCCC(N1CC2=C(CC1)NN=N2)=O VZSRBBMJRBPUNF-UHFFFAOYSA-N 0.000 description 2
- OZAIFHULBGXAKX-UHFFFAOYSA-N 2-(2-cyanopropan-2-yldiazenyl)-2-methylpropanenitrile Chemical compound N#CC(C)(C)N=NC(C)(C)C#N OZAIFHULBGXAKX-UHFFFAOYSA-N 0.000 description 2
- NUWOTWOOOHRWHB-UHFFFAOYSA-N 2-(2-phenylacetyl)oxyethyl prop-2-enoate Chemical compound C=CC(=O)OCCOC(=O)CC1=CC=CC=C1 NUWOTWOOOHRWHB-UHFFFAOYSA-N 0.000 description 2
- XFCMNSHQOZQILR-UHFFFAOYSA-N 2-[2-(2-methylprop-2-enoyloxy)ethoxy]ethyl 2-methylprop-2-enoate Chemical compound CC(=C)C(=O)OCCOCCOC(=O)C(C)=C XFCMNSHQOZQILR-UHFFFAOYSA-N 0.000 description 2
- VMZCDNSFRSVYKQ-UHFFFAOYSA-N 2-phenylacetyl chloride Chemical compound ClC(=O)CC1=CC=CC=C1 VMZCDNSFRSVYKQ-UHFFFAOYSA-N 0.000 description 2
- DJIGZOGWSBOMDM-UHFFFAOYSA-N 2-prop-2-enoyloxyethyl 3-phenylpropanoate Chemical compound C=CC(=O)OCCOC(=O)CCC1=CC=CC=C1 DJIGZOGWSBOMDM-UHFFFAOYSA-N 0.000 description 2
- ARZPBFMLJUHCRO-UHFFFAOYSA-N 2-prop-2-enoyloxyethyl furan-2-carboxylate Chemical compound C=CC(=O)OCCOC(=O)C1=CC=CO1 ARZPBFMLJUHCRO-UHFFFAOYSA-N 0.000 description 2
- NYQXLWKEZJYXMI-UHFFFAOYSA-N 2-prop-2-enoyloxyethyl thiophene-2-carboxylate Chemical compound C=CC(=O)OCCOC(=O)C1=CC=CS1 NYQXLWKEZJYXMI-UHFFFAOYSA-N 0.000 description 2
- MFEILWXBDBCWKF-UHFFFAOYSA-N 3-phenylpropanoyl chloride Chemical compound ClC(=O)CCC1=CC=CC=C1 MFEILWXBDBCWKF-UHFFFAOYSA-N 0.000 description 2
- JHWGFJBTMHEZME-UHFFFAOYSA-N 4-prop-2-enoyloxybutyl prop-2-enoate Chemical compound C=CC(=O)OCCCCOC(=O)C=C JHWGFJBTMHEZME-UHFFFAOYSA-N 0.000 description 2
- SOGAXMICEFXMKE-UHFFFAOYSA-N Butylmethacrylate Chemical compound CCCCOC(=O)C(C)=C SOGAXMICEFXMKE-UHFFFAOYSA-N 0.000 description 2
- CURLTUGMZLYLDI-UHFFFAOYSA-N Carbon dioxide Chemical compound O=C=O CURLTUGMZLYLDI-UHFFFAOYSA-N 0.000 description 2
- VEXZGXHMUGYJMC-UHFFFAOYSA-M Chloride anion Chemical compound [Cl-] VEXZGXHMUGYJMC-UHFFFAOYSA-M 0.000 description 2
- BAPJBEWLBFYGME-UHFFFAOYSA-N Methyl acrylate Chemical compound COC(=O)C=C BAPJBEWLBFYGME-UHFFFAOYSA-N 0.000 description 2
- 239000004721 Polyphenylene oxide Substances 0.000 description 2
- PPBRXRYQALVLMV-UHFFFAOYSA-N Styrene Chemical compound C=CC1=CC=CC=C1 PPBRXRYQALVLMV-UHFFFAOYSA-N 0.000 description 2
- HFBMWMNUJJDEQZ-UHFFFAOYSA-N acryloyl chloride Chemical compound ClC(=O)C=C HFBMWMNUJJDEQZ-UHFFFAOYSA-N 0.000 description 2
- 230000000996 additive effect Effects 0.000 description 2
- RMRJXGBAOAMLHD-IHFGGWKQSA-N buprenorphine Chemical compound C([C@]12[C@H]3OC=4C(O)=CC=C(C2=4)C[C@@H]2[C@]11CC[C@]3([C@H](C1)[C@](C)(O)C(C)(C)C)OC)CN2CC1CC1 RMRJXGBAOAMLHD-IHFGGWKQSA-N 0.000 description 2
- 239000012043 crude product Substances 0.000 description 2
- 150000002009 diols Chemical class 0.000 description 2
- KPUWHANPEXNPJT-UHFFFAOYSA-N disiloxane Chemical class [SiH3]O[SiH3] KPUWHANPEXNPJT-UHFFFAOYSA-N 0.000 description 2
- 239000000975 dye Substances 0.000 description 2
- SUPCQIBBMFXVTL-UHFFFAOYSA-N ethyl 2-methylprop-2-enoate Chemical compound CCOC(=O)C(C)=C SUPCQIBBMFXVTL-UHFFFAOYSA-N 0.000 description 2
- PNJWIWWMYCMZRO-UHFFFAOYSA-N pent‐4‐en‐2‐one Natural products CC(=O)CC=C PNJWIWWMYCMZRO-UHFFFAOYSA-N 0.000 description 2
- 229940067107 phenylethyl alcohol Drugs 0.000 description 2
- 239000004033 plastic Substances 0.000 description 2
- 229920003023 plastic Polymers 0.000 description 2
- 229920000570 polyether Polymers 0.000 description 2
- BWHMMNNQKKPAPP-UHFFFAOYSA-L potassium carbonate Chemical compound [K+].[K+].[O-]C([O-])=O BWHMMNNQKKPAPP-UHFFFAOYSA-L 0.000 description 2
- 239000007870 radical polymerization initiator Substances 0.000 description 2
- 150000003254 radicals Chemical class 0.000 description 2
- 229920002818 (Hydroxyethyl)methacrylate Polymers 0.000 description 1
- DNIAPMSPPWPWGF-GSVOUGTGSA-N (R)-(-)-Propylene glycol Chemical compound C[C@@H](O)CO DNIAPMSPPWPWGF-GSVOUGTGSA-N 0.000 description 1
- KWEKXPWNFQBJAY-UHFFFAOYSA-N (dimethyl-$l^{3}-silanyl)oxy-dimethylsilicon Chemical compound C[Si](C)O[Si](C)C KWEKXPWNFQBJAY-UHFFFAOYSA-N 0.000 description 1
- STMDPCBYJCIZOD-UHFFFAOYSA-N 2-(2,4-dinitroanilino)-4-methylpentanoic acid Chemical compound CC(C)CC(C(O)=O)NC1=CC=C([N+]([O-])=O)C=C1[N+]([O-])=O STMDPCBYJCIZOD-UHFFFAOYSA-N 0.000 description 1
- PKUZTKFHHPBGTD-UHFFFAOYSA-N 2-(2-methylprop-2-enoyloxy)ethyl 4-phenylbutanoate Chemical compound CC(=C)C(=O)OCCOC(=O)CCCC1=CC=CC=C1 PKUZTKFHHPBGTD-UHFFFAOYSA-N 0.000 description 1
- QVQIMDWZCCSZMB-UHFFFAOYSA-N 2-(2-methylprop-2-enoyloxy)ethyl thiophene-2-carboxylate Chemical compound CC(=C)C(=O)OCCOC(=O)C1=CC=CS1 QVQIMDWZCCSZMB-UHFFFAOYSA-N 0.000 description 1
- GHGQZCXZRRTYEH-UHFFFAOYSA-N 2-(2-phenylacetyl)oxyethyl 2-methylprop-2-enoate Chemical compound CC(=C)C(=O)OCCOC(=O)CC1=CC=CC=C1 GHGQZCXZRRTYEH-UHFFFAOYSA-N 0.000 description 1
- ZXPBVUYXWQKTIB-UHFFFAOYSA-N 2-(3-phenylpropanoyloxy)ethyl 2-methylprop-2-enoate Chemical compound CC(=C)C(=O)OCCOC(=O)CCC1=CC=CC=C1 ZXPBVUYXWQKTIB-UHFFFAOYSA-N 0.000 description 1
- FJGQBLRYBUAASW-UHFFFAOYSA-N 2-(benzotriazol-2-yl)phenol Chemical compound OC1=CC=CC=C1N1N=C2C=CC=CC2=N1 FJGQBLRYBUAASW-UHFFFAOYSA-N 0.000 description 1
- OFTKFKYVSBNYEC-UHFFFAOYSA-N 2-furoyl chloride Chemical compound ClC(=O)C1=CC=CO1 OFTKFKYVSBNYEC-UHFFFAOYSA-N 0.000 description 1
- 125000000954 2-hydroxyethyl group Chemical group [H]C([*])([H])C([H])([H])O[H] 0.000 description 1
- VAPQAGMSICPBKJ-UHFFFAOYSA-N 2-nitroacridine Chemical compound C1=CC=CC2=CC3=CC([N+](=O)[O-])=CC=C3N=C21 VAPQAGMSICPBKJ-UHFFFAOYSA-N 0.000 description 1
- PWTLVJUQHIFNKF-UHFFFAOYSA-N 2-prop-2-enoyloxyethyl 4-phenylbutanoate Chemical compound C=CC(=O)OCCOC(=O)CCCC1=CC=CC=C1 PWTLVJUQHIFNKF-UHFFFAOYSA-N 0.000 description 1
- HTWRFCRQSLVESJ-UHFFFAOYSA-N 3-(2-methylprop-2-enoyloxy)propyl 2-methylprop-2-enoate Chemical compound CC(=C)C(=O)OCCCOC(=O)C(C)=C HTWRFCRQSLVESJ-UHFFFAOYSA-N 0.000 description 1
- OVLOMMUYAPLPFF-UHFFFAOYSA-N 3-(2-methylprop-2-enoyloxy)propyl benzoate Chemical compound CC(=C)C(=O)OCCCOC(=O)C1=CC=CC=C1 OVLOMMUYAPLPFF-UHFFFAOYSA-N 0.000 description 1
- AMZNFNXOVYDPBW-UHFFFAOYSA-N 3-[[dimethyl(3-prop-2-enoyloxypropyl)silyl]oxy-dimethylsilyl]propyl prop-2-enoate Chemical compound C=CC(=O)OCCC[Si](C)(C)O[Si](C)(C)CCCOC(=O)C=C AMZNFNXOVYDPBW-UHFFFAOYSA-N 0.000 description 1
- VMAHHQWSPJHCCR-UHFFFAOYSA-N 3-prop-2-enoyloxypropyl benzoate Chemical compound C=CC(=O)OCCCOC(=O)C1=CC=CC=C1 VMAHHQWSPJHCCR-UHFFFAOYSA-N 0.000 description 1
- KYAAQBHLQWIHHH-UHFFFAOYSA-N 4-(2-methylprop-2-enoyloxy)butyl benzoate Chemical compound CC(=C)C(=O)OCCCCOC(=O)C1=CC=CC=C1 KYAAQBHLQWIHHH-UHFFFAOYSA-N 0.000 description 1
- NDWUBGAGUCISDV-UHFFFAOYSA-N 4-hydroxybutyl prop-2-enoate Chemical compound OCCCCOC(=O)C=C NDWUBGAGUCISDV-UHFFFAOYSA-N 0.000 description 1
- SODSOJXSURAGBW-UHFFFAOYSA-N 4-prop-2-enoyloxybutyl 3-phenylpropanoate Chemical compound C=CC(=O)OCCCCOC(=O)CCC1=CC=CC=C1 SODSOJXSURAGBW-UHFFFAOYSA-N 0.000 description 1
- HUEUFXBZRRMAFS-UHFFFAOYSA-N 4-prop-2-enoyloxybutyl benzoate Chemical compound C=CC(=O)OCCCCOC(=O)C1=CC=CC=C1 HUEUFXBZRRMAFS-UHFFFAOYSA-N 0.000 description 1
- SAPGBCWOQLHKKZ-UHFFFAOYSA-N 6-(2-methylprop-2-enoyloxy)hexyl 2-methylprop-2-enoate Chemical compound CC(=C)C(=O)OCCCCCCOC(=O)C(C)=C SAPGBCWOQLHKKZ-UHFFFAOYSA-N 0.000 description 1
- 208000002177 Cataract Diseases 0.000 description 1
- 101710112752 Cytotoxin Proteins 0.000 description 1
- JIGUQPWFLRLWPJ-UHFFFAOYSA-N Ethyl acrylate Chemical compound CCOC(=O)C=C JIGUQPWFLRLWPJ-UHFFFAOYSA-N 0.000 description 1
- CERQOIWHTDAKMF-UHFFFAOYSA-N Methacrylic acid Chemical compound CC(=C)C(O)=O CERQOIWHTDAKMF-UHFFFAOYSA-N 0.000 description 1
- VVQNEPGJFQJSBK-UHFFFAOYSA-N Methyl methacrylate Chemical compound COC(=O)C(C)=C VVQNEPGJFQJSBK-UHFFFAOYSA-N 0.000 description 1
- WHNWPMSKXPGLAX-UHFFFAOYSA-N N-Vinyl-2-pyrrolidone Chemical compound C=CN1CCCC1=O WHNWPMSKXPGLAX-UHFFFAOYSA-N 0.000 description 1
- 238000005481 NMR spectroscopy Methods 0.000 description 1
- 239000002202 Polyethylene glycol Substances 0.000 description 1
- GOOHAUXETOMSMM-UHFFFAOYSA-N Propylene oxide Chemical compound CC1CO1 GOOHAUXETOMSMM-UHFFFAOYSA-N 0.000 description 1
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 150000001252 acrylic acid derivatives Chemical class 0.000 description 1
- 125000003710 aryl alkyl group Chemical group 0.000 description 1
- 150000001540 azides Chemical class 0.000 description 1
- WPYMKLBDIGXBTP-UHFFFAOYSA-N benzoic acid Chemical compound OC(=O)C1=CC=CC=C1 WPYMKLBDIGXBTP-UHFFFAOYSA-N 0.000 description 1
- RWCCWEUUXYIKHB-UHFFFAOYSA-N benzophenone Chemical compound C=1C=CC=CC=1C(=O)C1=CC=CC=C1 RWCCWEUUXYIKHB-UHFFFAOYSA-N 0.000 description 1
- 150000008366 benzophenones Chemical class 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 229920001400 block copolymer Polymers 0.000 description 1
- 238000009835 boiling Methods 0.000 description 1
- 239000001569 carbon dioxide Substances 0.000 description 1
- 229910002092 carbon dioxide Inorganic materials 0.000 description 1
- 125000003262 carboxylic acid ester group Chemical group [H]C([H])([*:2])OC(=O)C([H])([H])[*:1] 0.000 description 1
- 125000004218 chloromethyl group Chemical group [H]C([H])(Cl)* 0.000 description 1
- 238000000576 coating method Methods 0.000 description 1
- 238000002425 crystallisation Methods 0.000 description 1
- 230000008025 crystallization Effects 0.000 description 1
- 231100000599 cytotoxic agent Toxicity 0.000 description 1
- 239000002619 cytotoxin Substances 0.000 description 1
- 238000000354 decomposition reaction Methods 0.000 description 1
- 125000004386 diacrylate group Chemical group 0.000 description 1
- 239000003085 diluting agent Substances 0.000 description 1
- 229910001873 dinitrogen Inorganic materials 0.000 description 1
- 238000004090 dissolution Methods 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 description 1
- 125000000816 ethylene group Chemical group [H]C([H])([*:1])C([H])([H])[*:2] 0.000 description 1
- 238000001914 filtration Methods 0.000 description 1
- 239000007789 gas Substances 0.000 description 1
- 239000011521 glass Substances 0.000 description 1
- 230000009477 glass transition Effects 0.000 description 1
- 239000012456 homogeneous solution Substances 0.000 description 1
- 229920001519 homopolymer Polymers 0.000 description 1
- 230000007062 hydrolysis Effects 0.000 description 1
- 238000006460 hydrolysis reaction Methods 0.000 description 1
- 230000001939 inductive effect Effects 0.000 description 1
- 239000011159 matrix material Substances 0.000 description 1
- DNIAPMSPPWPWGF-UHFFFAOYSA-N monopropylene glycol Natural products CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 1
- YLGYACDQVQQZSW-UHFFFAOYSA-N n,n-dimethylprop-2-enamide Chemical compound CN(C)C(=O)C=C YLGYACDQVQQZSW-UHFFFAOYSA-N 0.000 description 1
- MMCOUVMKNAHQOY-UHFFFAOYSA-L oxido carbonate Chemical compound [O-]OC([O-])=O MMCOUVMKNAHQOY-UHFFFAOYSA-L 0.000 description 1
- 150000002978 peroxides Chemical class 0.000 description 1
- 150000004978 peroxycarbonates Chemical class 0.000 description 1
- 125000000286 phenylethyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])C([H])([H])* 0.000 description 1
- 230000000704 physical effect Effects 0.000 description 1
- 229920003229 poly(methyl methacrylate) Polymers 0.000 description 1
- 229920000058 polyacrylate Polymers 0.000 description 1
- 229920001223 polyethylene glycol Polymers 0.000 description 1
- 239000002861 polymer material Substances 0.000 description 1
- 239000004926 polymethyl methacrylate Substances 0.000 description 1
- 229920001296 polysiloxane Polymers 0.000 description 1
- 229910000027 potassium carbonate Inorganic materials 0.000 description 1
- 239000002243 precursor Substances 0.000 description 1
- FBCQUCJYYPMKRO-UHFFFAOYSA-N prop-2-enyl 2-methylprop-2-enoate Chemical compound CC(=C)C(=O)OCC=C FBCQUCJYYPMKRO-UHFFFAOYSA-N 0.000 description 1
- 229960004063 propylene glycol Drugs 0.000 description 1
- 235000013772 propylene glycol Nutrition 0.000 description 1
- 238000010526 radical polymerization reaction Methods 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 239000011343 solid material Substances 0.000 description 1
- 239000001117 sulphuric acid Substances 0.000 description 1
- 235000011149 sulphuric acid Nutrition 0.000 description 1
- 238000001356 surgical procedure Methods 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- 125000000383 tetramethylene group Chemical group [H]C([H])([*:1])C([H])([H])C([H])([H])C([H])([H])[*:2] 0.000 description 1
- QIQITDHWZYEEPA-UHFFFAOYSA-N thiophene-2-carbonyl chloride Chemical compound ClC(=O)C1=CC=CS1 QIQITDHWZYEEPA-UHFFFAOYSA-N 0.000 description 1
- 231100000331 toxic Toxicity 0.000 description 1
- 230000002588 toxic effect Effects 0.000 description 1
- 230000002110 toxicologic effect Effects 0.000 description 1
- 231100000027 toxicology Toxicity 0.000 description 1
- 238000002834 transmittance Methods 0.000 description 1
- 238000005292 vacuum distillation Methods 0.000 description 1
- 125000000391 vinyl group Chemical group [H]C([*])=C([H])[H] 0.000 description 1
- 239000001043 yellow dye Substances 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C67/00—Preparation of carboxylic acid esters
- C07C67/14—Preparation of carboxylic acid esters from carboxylic acid halides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/02—Prostheses implantable into the body
- A61F2/14—Eye parts, e.g. lenses, corneal implants; Implanting instruments specially adapted therefor; Artificial eyes
- A61F2/16—Intraocular lenses
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C69/00—Esters of carboxylic acids; Esters of carbonic or haloformic acids
- C07C69/612—Esters of carboxylic acids having a carboxyl group bound to an acyclic carbon atom and having a six-membered aromatic ring in the acid moiety
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C69/00—Esters of carboxylic acids; Esters of carbonic or haloformic acids
- C07C69/612—Esters of carboxylic acids having a carboxyl group bound to an acyclic carbon atom and having a six-membered aromatic ring in the acid moiety
- C07C69/614—Esters of carboxylic acids having a carboxyl group bound to an acyclic carbon atom and having a six-membered aromatic ring in the acid moiety of phenylacetic acid
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C69/00—Esters of carboxylic acids; Esters of carbonic or haloformic acids
- C07C69/76—Esters of carboxylic acids having a carboxyl group bound to a carbon atom of a six-membered aromatic ring
- C07C69/78—Benzoic acid esters
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08F—MACROMOLECULAR COMPOUNDS OBTAINED BY REACTIONS ONLY INVOLVING CARBON-TO-CARBON UNSATURATED BONDS
- C08F120/00—Homopolymers of compounds having one or more unsaturated aliphatic radicals, each having only one carbon-to-carbon double bond, and only one being terminated by only one carboxyl radical or a salt, anhydride, ester, amide, imide or nitrile thereof
- C08F120/62—Monocarboxylic acids having ten or more carbon atoms; Derivatives thereof
- C08F120/68—Esters
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08F—MACROMOLECULAR COMPOUNDS OBTAINED BY REACTIONS ONLY INVOLVING CARBON-TO-CARBON UNSATURATED BONDS
- C08F220/00—Copolymers of compounds having one or more unsaturated aliphatic radicals, each having only one carbon-to-carbon double bond, and only one being terminated by only one carboxyl radical or a salt, anhydride ester, amide, imide or nitrile thereof
- C08F220/62—Monocarboxylic acids having ten or more carbon atoms; Derivatives thereof
- C08F220/68—Esters
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08F—MACROMOLECULAR COMPOUNDS OBTAINED BY REACTIONS ONLY INVOLVING CARBON-TO-CARBON UNSATURATED BONDS
- C08F228/00—Copolymers of compounds having one or more unsaturated aliphatic radicals, each having only one carbon-to-carbon double bond, and at least one being terminated by a bond to sulfur or by a heterocyclic ring containing sulfur
- C08F228/06—Copolymers of compounds having one or more unsaturated aliphatic radicals, each having only one carbon-to-carbon double bond, and at least one being terminated by a bond to sulfur or by a heterocyclic ring containing sulfur by a heterocyclic ring containing sulfur
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08F—MACROMOLECULAR COMPOUNDS OBTAINED BY REACTIONS ONLY INVOLVING CARBON-TO-CARBON UNSATURATED BONDS
- C08F220/00—Copolymers of compounds having one or more unsaturated aliphatic radicals, each having only one carbon-to-carbon double bond, and only one being terminated by only one carboxyl radical or a salt, anhydride ester, amide, imide or nitrile thereof
- C08F220/02—Monocarboxylic acids having less than ten carbon atoms; Derivatives thereof
- C08F220/10—Esters
- C08F220/12—Esters of monohydric alcohols or phenols
- C08F220/16—Esters of monohydric alcohols or phenols of phenols or of alcohols containing two or more carbon atoms
- C08F220/18—Esters of monohydric alcohols or phenols of phenols or of alcohols containing two or more carbon atoms with acrylic or methacrylic acids
- C08F220/1804—C4-(meth)acrylate, e.g. butyl (meth)acrylate, isobutyl (meth)acrylate or tert-butyl (meth)acrylate
Definitions
- the invention concerns optical devices; especially intraocular lens made from high refractive index polymers prepared from hydroxyalkyl acrylates and methacrylates containing aromatic groups and carbonyl groups.
- the invention also relates to the starting monomers, the polymers prepared; the application of the same for the manufacture of optical devices and the products derived therefrom.
- plastic lenses are implanted in the eye, wherein an incision is made and the plastic lens is inserted through the incision.
- the rigid polymethyl methacrylate lenses previously used have been replaced with soft lenses, which are thin and flexible enough to be inserted into the eye through a smaller incision, in a folded state, where they unfold and take their place.
- Intraocular lens types and their properties are described in several references. A good overview of the topic is provided by, for example, U.S. Patent No. 7,387,642 or U.S. Patent No. 6,635,732.
- the refractive power of the lens depends on the shape and the material of which it is made, the higher the refractive index of a material is, the thinner lens can be used to provide the same refractive power. Therefore, said requirements are met by a polymer that is soft and has a high refractive index. However, it is important that the polymer lens material should be biocompatible.
- U.S. Pat. No. 5,290,892 discloses a solution according to which acrylates and methacrylates containing aromatic groups, especially phenyl ethyl acrylate (PEA) and phenyl ethyl methacrylate (PEMA), were used as a copolymer material for the preparation of IOL lenses.
- PPA phenyl ethyl acrylate
- PEMA phenyl ethyl methacrylate
- the phenyl group provides the high refractive index of about 1.5 to 1.6.
- the soft IOL lens is always composed of a copolymer prepared from different monomers, especially PEA/PEMA system, i.e. it is a multi-phase system, the composition of which cannot be given with perfect accuracy, which affects the constancy of physical properties as well.
- the starting acrylate or methacrylate monomer used to prepare the intraocular lens contains both aromatic and carbonyl groups.
- the invention is based on this recognition.
- the invention relates to a biocompatible, hydrophobic, soft, high refractive index intraocular lens, wherein an aikane diol derivative is used as a starting monomer, which contains an aryl or aralkyl carboxylic acid ester group on one end, and an acrylic or methacrylic acid ester group to ensure polymerization on the other end.
- the invention relates to the above starting compounds, the process for the preparation of the same, the polymers prepared therefrom and the use of the compounds for the preparation of optical devices, particularly intraocular lenses.
- the invention also covers the preparation of intraocular lenses.
- the common abbreviation (IOL) is used herein to refer to an intraocular lens.
- the hydrophobic, soft, biocompatible, high- refractive index intraocular lens according to the invention is prepared from aikane diol derivatives containing an aryl or aralkyl carboxylic acid ester on one end and an acrylic or methacrylic acid ester on the other end.
- Ar represents a substituted aromatic group, preferably a phenyl, biphenylyl, naphthyl, thienyl, furyl, pyrrolyl group, the substituent is one or more hydroxyl, alkyl, alkoxy, alkoxycarbonyl, amino, nitro groups, a halogen atom, wherein the alkyl group may be straight or branched and has 1 to 6 carbon atoms;
- n is an integer of 2, 3, 4, 5 10;
- f is an integer of 0, 1 , 2, 3 10;
- X represents a hydrogen atom or a methyl group
- Ri , R2, R3, 4 are the same or different and independently represent a hydrogen or halogen atom, an alkyl group having 1 to 4 carbon atoms, a hydroxyl or a carboxyl group.
- Ar preferably represents an unsubstituted phenyl, thienyl, furyl or pyrrolyl group, particularly preferably a phenyl group, f preferably represents 0, 1 or 2, particularly preferably 0, n is preferably 2, 3 or 4, particularly preferably 2, whereas Ri, R 2 , R3, R4 each preferably represent a hydrogen atom.
- Preferred compounds are thus the co-(co-phenylalkanoyloxy)alkyl acrylates, the ⁇ -( ⁇ - phenylalkanoyloxy)alkyl methacrylates, the co-[co-(thiophene-2-yl)alkanoyloxy]alkyl acrylates, the (o-[o)-(thiophene-2-yl)alkanoyloxy]alkyl methacrylates, the o-[co-(furan-2-yl)- alkanoyloxy]alkyl acrylates, the (o-[eo-(furan-2-yl)alkanoyloxy]alkyl methacrylates.
- Furyl derivatives included in the compounds of the general formula (I) are described in U.S. Pat. No. 4,663,41 1. The compounds are used as binders or in the manufacture of coatings.
- Example 1 1 of WO03/018648 describes a thienyl derivative [2-(thiophene-2-ylcarbonyl)ethyl methacrylate] belonging to compounds of the general formula (I), as the precursor of electrically conductive block copolymers. The said document does not contain any indication as to whether the compounds would be suitable for the preparation of intraocular lenses.
- WO02/077044 discloses hydrophilic monomers comprising polyether chains, which are different from the hydrophobic compounds according to our invention, for the preparation of contact lenses and IOL lenses.
- this particular compound and the preparation of this very compound is not presented, since the document discloses a synthesis starting from a polyether (as a first step, oligoether is prepared from 1 ,2-propanediol with propylene oxide, which has about 6 members).
- Ar' represents a mono- or polysubstituted phenyl, biphenylyl, naphthyl or pyrrolyl group, wherein the substituent is a hydroxyl, alkyl, alkoxy, alkoxycarbonyl, amino, nitro group, a halogen atom, such as chlorine, bromine, fluorine, the alkyl and alkoxy groups have 1 to 6 carbon atoms and may be straight or branched;
- n' is an integer of 2, 3, 4, 5 10;
- f is an integer of 0, 1 , 2, 3 10;
- X' represents a hydrogen atom or a methyl group
- R]', R 2 ⁇ R3 ' , R4 ' are the same or different and independently represent a hydrogen or halogen atom, an alkyl group having 1 to 4 carbon atoms, a hydroxyl or a carboxyl group.
- a compound of the general formula Ar-((CRiR 2 ) f -C(0)-0- (CR 3 R4) n -OH, wherein Ar, Ri, R 2 , R 3 , R ⁇ f and n are the same as in the general formula (I), is reacted with a compound of the general formula CH 2 C(X)-C(0)-L; in this latter formula, X is the same as in the general formula (I), L represents a leaving group, for example, a halogen atom, such as chlorine, bromine, fluorine or iodine; the reaction is carried out in the presence of an acid- binding agent, such as triethylamine, in a solvent, for example, an organic solvent, such as diethyl ether, ethyl acetate, acetone or other suitable solvent.
- an acid- binding agent such as triethylamine
- the invention also relates to the process for the preparation of compounds of the general formula ( ⁇ ).
- a further object of the invention is the use of the compounds of the general formula (I) as defined above for the preparation of optical devices such as contact lenses, IOL, especially in the preparation of IOL.
- the invention also extends to the preparation of polymers from compounds of the general formula (I) as monomers, the prepared polymers and the use thereof for the preparation of optical devices.
- Monomers of the general formula (I) are suitable on their own for the preparation of homopolymers appropriate for optical devices such as intraocular lenses, but they can also be copolymerized with other known acrylate and methacrylate type monomers in order to prepare two- or three-, possibly multi-component copolymers.
- Such co-monomers include, but are not limited to the following: methyl acrylate, methyl methacrylate, ethyl acrylate, ethyl methacrylate, butyl acrylate, butyl methacrylate, 2-hydroxyethyl acrylate (HEA), 2-hydroxyethyl methacrylate (HEMA), acrylic acid, methacrylic acid, NN-dimethylacrylamide, N-vinylpyrrolidone, styrene, polyethylene glycol monoacrylate and methacrylate, etc.
- the invention includes the joint use of compounds of the general formula (I) and such co-monomers for the preparation of optical devices, e.g., contact lenses, IOL, especially IOL.
- copolymers are prepared from the above monomers with the use of known copolymerizable cross-linking agents. With these, the rheological properties of monomers can be changed.
- cross-linking agents to be used include, but are not limited to the following: ethylene glycol dimethacrylate, diethylene glycol dimethacrylate, allyl methacrylate, 1 ,3- propanediol dimethacrylate, 1,6-hexanediol dimethacrylate, 1 ,4-butanediol diacrylate and dimethacrylate and the like.
- cross-linking agents preferably ethylene glycol dimethacrylate (EGDMA), 1 ,4-butanediol diacrylate (BDDA) or dimethacrylate (BDDMA) are used.
- Organic silicone diacrylate and dimethacrylate compounds may also be used as a cross- linking agent, including the following compounds of the general formulae (Ila, lib),
- X represents a hydrogen atom or a methyl group
- n is 1 , 2, 3, 4, 5 or 6 and m is 0 or an integer between 1 and 20, and
- X represents a hydrogen atom or a methyl group and n is 1, 2, 3, 4, 5 or 6, m is 0 or an integer between 1 and 20.
- Preferred compounds of the general formula (II) include, but are not limited to the following siloxane-based monomers: l ,3-bis(acryloyloxymethyl)- l , l,3,3-tetramethyldisiloxane, 1 ,3-bis(acryloyloxypropyl)- 1 , 1 ,3,3-tetramethyldisiloxane, ⁇ (Tetramethyldisiloxane- 1 ,3-diyl) bis[propane-3, l-diyloxy(2-hydroxypropane-3,l-diyl)] ⁇ diacrylate, etc.
- auxiliary materials and additives can also be integrated in copolymers used for intraocular lenses. Examples include:
- Ultraviolet absorbing compounds such as substituted benzophenones like 2- hyroxybenzophenone, 2-(2-hydroxyphenyl)-2H-benzotriazol, or the photostabilizers mentioned in U.S. Patent No. 4,304,895, or the 2-(2-hydroxy-5-acryloyloxyphenyl>2H-benzotriazol or 2-[3-(2- methylallyl>2-hydroxy-5-methylphenyl]-2H-benzotriazol included in U.S. Patent No. 4,528,3 1 1.
- Colour filter dyes making the lens yellow by filtering the blue light can also be used as an additive.
- Such dyes are disclosed, for example, in the following documents: U.S. 2003/0078359, U.S. 6,310,215, U.S. 5,662,707, U.S. 5,543,504, U.S. 5,528,322, and U.S. 5,470,932.
- the said yellow dyes contain active vinyl groups, which are incorporated in the polymer matrix, so they do not dissolve from the lens, and influence the vision through the yellow colour thereof.
- Examples of the compounds include, but are not limited to, the following: 4-[4-(allyloxycarbonyl)phenylazo]-l- phenyl-3-methylpyrazol-5-on, l-phenyl-3-methyl-4-(4-vinylphenylazo)pyrazol-5-on, l-phenyl-3- methyl-5-oxopyrazol-4-carbaldehyde (MPCA),NN-bis (methaciyloylethyl)-/?-aminoazobenzene.
- the polymer or copolymer forming the raw material of the intraocular lens is prepared by a known polymerization process.
- the invention also involves the process of preparing polymers from new monomers.
- the invention applies in particular to a polymer preparation process, wherein a tetrafunctional disiloxane of the general formula (Ila) or (lib) is used as a cross-linking agent; substituents in the formulae are the same as above.
- Polymerization can be carried out by using free radical initiators, such as thermally decomposing peroxides, azides, or it can be carried out with the use of photoinitiators, for example, UV light, inducing radical polymerization.
- free radical initiators such as thermally decomposing peroxides, azides
- photoinitiators for example, UV light, inducing radical polymerization.
- free radical initiators benzophenone peroxide, peroxycarbonates, bis-(4-/err-butylcyclohexyl) peroxycarbonate, azonitriles, for example, azobisisobutyronitrile.
- Photoinitiators are generally of benzophenone type.
- the refractive index of the soft IOL polymers according to the invention is around 1.5, the glass transition temperature thereof corresponds to the given use.
- the materials used are either prepared by us or purchased from commercial sources.
- BEA 2-(benzoyloxy)ethyl acrylate or 2-(acryloyloxy)ethyl benzoate
- EGDMA ethylene glycol dimethacrylate or ethane- l ,2-diyl-bis(2-methacrylate)
- BDDMA butanediol dimethacrylate or butane- l,4-diyl-bis(2-methacr late)
- FEA 2-(furan-2-ylcarbonyloxy)ethyl acrylate
- HEM A hydroxyethyl methacrylate
- SD A 1 ,3 -bis(acry loyloxymethy 1)- 1 , 1 ,3,3 -tetramethyldisiloxane
- UV ultraviolet light-absorbing compound
- a 500-ml four-necked flask equipped with a thermometer, a reflux condenser closed with a CaCl 2 tube, a stirrer and a dropping funnel is charged with 90.0 g (0.7965 mol) of potassium acrylate (which was previously prepared from acrylic acid and potassium carbonate), 2.0 g of hydroquinone and 200 ml of dimethylformamide.
- the reaction mixture is heated until dissolution and then 77.0 g (0.3333 mol) of (ClCH 2 SiMe 2)2 0, i.e. 1.3-bis(chloromethyl)-l,l,3,3,-tetramethyldisiloxane is slowly added thereto.
- the reaction mixture is boiled for 6 hours and then the KCl salt formed is filtered over a G3 glass filter. 80% of the solvent is distilled off, the residue is dissolved in 300 ml of diethyl ether, washed four times with distilled water and then dried overnight over CaCl 2. The mixture is filtered, the solvent is distilled off and the residue is distilled under vacuum.
- a 1500-ml four-necked flask equipped with a thermometer, a reflux condenser closed with a CaCl 2 tube, a stirrer and a dropping funnel is charged with 1000 ml of ethyl acetate, 2.0 g of hydroquinone and 250 g (1 mol) of l ,3-bis(hydroxypropyl)-l,l,3,3-tetramethyldisiloxane.
- the reaction mixture is cooled to 5 °C; 190 g (2.1 mol) of acryloyl chloride is slowly added thereto and then stirred for 6 hours.
- the crude product obtained is deinhibited as described in reference example 1.
- a 250-ml four-necked flask equipped with a thermometer, a reflux condenser closed with a CaCl 2 tube, a stirrer and a dropping funnel is charged with 65.2 g (0.2 mol) of allyl glycidyl ether, 0.4 g hydroquinone, 0.5 ml of concentrated sulphuric acid and 28.8 g (0.4 mol) acrylic acid.
- the reaction mixture is stirred for 6 hours at a temperature between 70-80 °C and then allowed to cool to room temperature. It is deinhibited as described in reference example 1.
- n d 25 1.464.
- a 2-liter apparatus equipped with a stirrer, a dropping funnel, a thermometer, a reflux condenser and a calcium chloride tube is charged with 700 ml of ethyl acetate, 202 g (2 mol) of triethylamine, 62 g (1 mol) of ethylene glycol, under nitrogen stream and 285 g (2 mol) of benzoyl chloride is added dropwise thereto for about 1 hour.
- the reaction mixture is stirred for 4 hours and allowed to stand overnight.
- 250 ml of 1 N hydrochloric acid is added thereto, stirred for 10 minutes and the phases are separated.
- the organic phase is washed twice with 1 N hydrochloric acid solution and then washed neutral with water.
- the organic phase is then dried over anhydrous calcium chloride, filtered, and the solvent is distilled. 264.2 g of the title compound is obtained, yield 97.9%. After crystallization from methanol, a white, solid material is obtained.
- a one-liter flask equipped with a magnetic stirrer, a calcium chloride tube and a reflux condenser is charged with 264.2 g (0.978 mol) of melted ethylene dibenzoate prepared according to the previous step, and then 270 g (4.35 mol) of ethylene glycol and 2.0 g of potassium hydroxide are added thereto.
- the reaction mixture is stirred for 16 hours at 160-170 C in oil bath, thus a homogeneous solution is obtained, which is allowed to cool to room temperature, and then the potassium hydroxide is neutralized with carbon dioxide gas.
- the desired compound is separated by vacuum distillation. 221.0 g of 2-hydroxyethyl benzoate is obtained, yield 66.6%.
- a 2-liter flask equipped with a stirrer, a thermometer, a nitrogen inlet, a dropping funnel and a reflux condenser is charged with 107.0 g (1.06 mol) of triethylamine, 166.0 g (1 mol) of 2- hydroxyethyl benzoate prepared according to the previous step and 600 ml of ethyl acetate.
- 95.0 g (1.05 mol) of acryloyl chloride is added dropwise to the reaction mixture while cooling in ice, in the meantime the temperature thereof rises to 10 °C, it is stirred for 5 hours at this temperature, then allowed to stand overnight.
- n D 20 1.5150.
- a 2-liter four-necked round-bottom flask equipped with a stirrer, a reflux condenser closed with a CaCl 2 tube, a thermometer and a dropping funnel is charged with 1 12.0 g (1.1 mol) of triethylamine, 1 16.0 g (1 mol) of HEA, 600 ml of ethyl acetate and 0.40 g of hydroquinone stabilizer washed in with ethyl acetate.
- Moist air is displaced with anhydrous nitrogen stream, and the nitrogen stream is maintained until the end of the reaction. Internal space is cooled to +4 °C with outside cooling in ice.
- the product is deinhibited as described in reference example 1.
- the process is the same as described in example 2, with the difference that 51 g (0.5 mol) triethylamine, 65 g (0.5 mol) of 2-hydroxyethyl methacrylate, 0.4 g of hydroquinone, 70.3 g (0, 5 mol) of benzoyl chloride and 500 ml of ethyl acetate is used.
- a 2-liter four-necked round-bottom flask equipped with a stirrer, a reflux condenser closed with a CaC tube, a thermometer and a dropping funnel is charged with 1 12.0 g ( 1.1 mol) of triethylamine, 116.0 g (1 mol) of HEA, 600 ml of ethyl acetate and 0.40 g of hydroquinone stabilizer washed in with ethyl acetate.
- Moist air is displaced with anhydrous nitrogen stream, and the nitrogen stream is maintained until the end of the reaction. Internal space is cooled to +4 °C with outside cooling in ice.
- the product is deinhibited as described above.
- a 2-liter four-necked round-bottom flask equipped with a stirrer, a reflux condenser closed with a CaCl 2 tube, a thermometer and a dropping funnel is charged with 1 12.0 g ( 1.1 mol) of triethylamine, 144.0 g ( 1 mol) of 4-hydroxybutyl acrylate, 600 ml of ethyl acetate and 0.40 g of hydroquinone stabilizer washed in with ethyl acetate.
- Moist air is displaced with anhydrous nitrogen stream, and the nitrogen stream is maintained until the end of the reaction. Internal space is cooled to +4 °C with outside cooling in ice.
- the product is deinhibited as described above.
- a flask is charged with 196 g of BEA and 3 g of EGDMA. 0.3 g of initiator is added thereto, and the mixture is stirred intensively at 25 °C under a stream of nitrogen gas for 30 minutes. The monomer mixture is filled in an apparatus, then polymerized at 60 °C for 12 hours, and post- polymerized at 90 °C for 24 hours.
- Discs of 13 to 17 mm in diameter and 2 to 3.5 mm thick are formed from the finished polymer sheets.
- the finished discs are post-treated at 90 °C for 168 hours, then machining the same, lenses and test specimens are made therefrom.
- the process is the same as described in example 11 , with the difference that 189 g of BEA, 10 g of EGDMA, and 0.3 g of initiator are used.
- the process is the same as described in example 11, with the difference that 191 g of BEA, 7.9 g of BDDMA-t and 0.6 g of initiator are used.
- the process is the same as described in example 11, with the difference that 185.8 g of BEA, 14.2 g of SDA, and 0.14 g of initiator are used.
- the process is the same as described in example 11, with the difference that 85 g of BEA, 106 g of fractionated BA, 1.4 g of UV and 7 g of EGDMA, as well as 0.28 g of initiator are used.
- Copolymer preparation from BEA with 56% BA and 3.7% EGDMA The process is the same as described in example 1 1 , with the difference that 78 g of BEA, 1 12.7 g of fractionated BA, 1.4 g of UV-t and 7.4 g of EGDMA, as well as 0.3 g of initiator are used.
- the process is the same as described in example 11, with the difference that 67.7 g of BEA, 122.2 g of fractionated BA, 1.6 g of UV and 8 g of EGDMA, as well as 0.32 g initiator are used.
- the process is the same as described in example 11, with the difference that 71 g of BEMA, 1 18.8 g of fractionated BA, 1.56 g of UV and 7.8 g of EGDMA, as well as 0.31 g of initiator are used.
- Discs of 14 to 16 mm in diameter and 3 mm thick were formed from the polymer materials thus prepared, which served as a raw material for the test specimens and the lenses made therefrom. Refractive index and transmittance were determined for the test specimens prepared. Injectability of lenses made with the same geometry from different materials was examined on the lenses prepared.
- compositions 1 and 2 The composition, physical constants, workability and elasticity of some polymers according to the invention are provided in Tables 1 and 2 below.
- Machining means turning under cooled conditions.
- Elasticity is a characteristic feature of injectability in case of a small wound.
- EGDMA ethane- 1,2-diyl bis(2-methacrylate) SDA l,3-bis(acryloyloxymethyl)-l , 1 ,3,3-tetramethyldisiloxane
- BDDMA butane- 1,4-diyl bis(2-methacrylate)
- INN Radical polymerization initiator
- the BEA-type material itself is suitable as a raw material for IOL lenses.
- the synthesized polymers were subjected to toxicological tests in accordance with USP 32 ⁇ 88> and it was found that the compounds were not toxic.
Abstract
The invention relates to optical devices; especially intraocular lens made from high refractive index polymers produced from hydroxyalkyl acrylates and methacrylates containing aromatic groups and carbonyl groups. The invention also relates to the starting monomers, the polymers produced; the application of the same for the manufacture of optical devices and the products derived therefrom.
Description
OPTICAL DEVICES
Field of the Invention
The invention concerns optical devices; especially intraocular lens made from high refractive index polymers prepared from hydroxyalkyl acrylates and methacrylates containing aromatic groups and carbonyl groups. The invention also relates to the starting monomers, the polymers prepared; the application of the same for the manufacture of optical devices and the products derived therefrom.
Background of the Invention
As the average age of mankind increases, more and more elderly people suffer from cataract.
In the course of a surgical procedure to solve the problem plastic lenses are implanted in the eye, wherein an incision is made and the plastic lens is inserted through the incision. To reduce the size of the incision, the rigid polymethyl methacrylate lenses previously used have been replaced with soft lenses, which are thin and flexible enough to be inserted into the eye through a smaller incision, in a folded state, where they unfold and take their place. Intraocular lens types and their properties are described in several references. A good overview of the topic is provided by, for example, U.S. Patent No. 7,387,642 or U.S. Patent No. 6,635,732.
Since the refractive power of the lens depends on the shape and the material of which it is made, the higher the refractive index of a material is, the thinner lens can be used to provide the same refractive power. Therefore, said requirements are met by a polymer that is soft and has a high refractive index. However, it is important that the polymer lens material should be biocompatible.
To meet the above requirements, U.S. Pat. No. 5,290,892 discloses a solution according to which acrylates and methacrylates containing aromatic groups, especially phenyl ethyl acrylate (PEA) and phenyl ethyl methacrylate (PEMA), were used as a copolymer material for the preparation of IOL lenses. In this solution, the phenyl group provides the high refractive index of about 1.5 to 1.6.
However, the use of these materials over a longer period may lead to the slight hydrolysis of PEA and PEMA, and as a result of decomposition, phenyl ethyl alcohol and acrylic polymer are formed. And phenyl ethyl alcohol is a major cytotoxin.
Another problem is that according to the document referred to (and also to other known solutions, e.g. U.S. Patent No. 6,635,732), the soft IOL lens is always composed of a copolymer prepared from different monomers, especially PEA/PEMA system, i.e. it is a multi-phase system, the composition of which cannot be given with perfect accuracy, which affects the constancy of physical properties as well.
There is thus a need for a raw material from which a soft, biocompatible, high refractive
index intraocular lens free from the disadvantages of the known solutions can be prepared.
Summary of the Invention
It has been recognized that these problems can be eliminated if the starting acrylate or methacrylate monomer used to prepare the intraocular lens contains both aromatic and carbonyl groups. The invention is based on this recognition.
The invention relates to a biocompatible, hydrophobic, soft, high refractive index intraocular lens, wherein an aikane diol derivative is used as a starting monomer, which contains an aryl or aralkyl carboxylic acid ester group on one end, and an acrylic or methacrylic acid ester group to ensure polymerization on the other end.
The invention relates to the above starting compounds, the process for the preparation of the same, the polymers prepared therefrom and the use of the compounds for the preparation of optical devices, particularly intraocular lenses.
The invention also covers the preparation of intraocular lenses. The common abbreviation (IOL) is used herein to refer to an intraocular lens.
Detailed Description of the Invention
The hydrophobic, soft, biocompatible, high- refractive index intraocular lens according to the invention is prepared from aikane diol derivatives containing an aryl or aralkyl carboxylic acid ester on one end and an acrylic or methacrylic acid ester on the other end.
These monomer compounds are preferably represented by the formula (I),
wherein
Ar represents a substituted aromatic group, preferably a phenyl, biphenylyl, naphthyl, thienyl, furyl, pyrrolyl group, the substituent is one or more hydroxyl, alkyl, alkoxy, alkoxycarbonyl, amino, nitro groups, a halogen atom, wherein the alkyl group may be straight or branched and has 1 to 6 carbon atoms;
n is an integer of 2, 3, 4, 5 10;
f is an integer of 0, 1 , 2, 3 10;
with the proviso that n + f < 15
X represents a hydrogen atom or a methyl group,
Ri , R2, R3, 4 are the same or different and independently represent a hydrogen or halogen atom, an alkyl group having 1 to 4 carbon atoms, a hydroxyl or a carboxyl group.
Compounds of the general formula (I) are therefore oo-(o)-arylalkanoyloxy)alkyl acrylates
and (O-(co-arylalkanoyloxy)alkyl methacrylates.
Ar preferably represents an unsubstituted phenyl, thienyl, furyl or pyrrolyl group, particularly preferably a phenyl group, f preferably represents 0, 1 or 2, particularly preferably 0, n is preferably 2, 3 or 4, particularly preferably 2, whereas Ri, R2, R3, R4 each preferably represent a hydrogen atom.
Preferred compounds are thus the co-(co-phenylalkanoyloxy)alkyl acrylates, the ω-(ω- phenylalkanoyloxy)alkyl methacrylates, the co-[co-(thiophene-2-yl)alkanoyloxy]alkyl acrylates, the (o-[o)-(thiophene-2-yl)alkanoyloxy]alkyl methacrylates, the o-[co-(furan-2-yl)- alkanoyloxy]alkyl acrylates, the (o-[eo-(furan-2-yl)alkanoyloxy]alkyl methacrylates.
Some preferred compounds of the general formula (I) are mentioned herein by name, too: 2-
(benzoyloxy)ethyl acrylate, 2-(benzoyloxy)ethyl methacrylate, 3-(benzoyloxy)propyl acrylate, 3- (benzoyloxy)propyl methacrylate, 4-(benzoyloxy)butyl acrylate, 4-(benzoyloxy)butyl methacrylate, 2-(phenylacetoxy)ethyl acrylate, 2-(phenylacetoxy)ethyl methacrylate, 2-(3- phenylpropanoyloxy)- ethyl acrylate, 2-(3-phenylpropanoyloxy)ethyl methacrylate, 2-(4-phenylbutanoyloxy)ethyl acrylate, 2-(4-phenylbutanoyloxy)ethyl methacrylate, 2-(thiophene-2-ylcarbonyloxy)elhyl acrylate, 2- (thiophene-2-ylcarbonyloxy)ethyl methacrylate, 2-(furan-2-ylcarbonyloxy)ethyl acrylate, 2-(furan- 2-ylcarbonyloxy)e1hyl methacrylate.
Furyl derivatives included in the compounds of the general formula (I) are described in U.S. Pat. No. 4,663,41 1. The compounds are used as binders or in the manufacture of coatings. Example 1 1 of WO03/018648 describes a thienyl derivative [2-(thiophene-2-ylcarbonyl)ethyl methacrylate] belonging to compounds of the general formula (I), as the precursor of electrically conductive block copolymers. The said document does not contain any indication as to whether the compounds would be suitable for the preparation of intraocular lenses.
Other compounds of the general formula (I) are new; the preparation and identification thereof has not been described, therefore the invention in one respect relates to these new compounds defined by the general formula (Γ). Note that the names of 2-(benzoyloxy)ethyl acrylate and 2-(benzoyloxy)ethyl methacrylate appear in several documents in the long list of starting compounds to be used for the preparation of polymers (see, for example, documents U.S. 20040260318A1 or WO2005051452A2), and the name of 2-(benzoyloxy)ethyl acrylate is listed among active diluents in U.S. Pat. No. 5,523,152, but the preparation thereof is not described, and data suitable for the identification thereof is not disclosed either. In addition, WO02/077044 discloses hydrophilic monomers comprising polyether chains, which are different from the hydrophobic compounds according to our invention, for the preparation of contact lenses and IOL lenses. In the said document, the end value of 1 for m in the general formula for monomers, in principle, would result in a compound that corresponds to the case of the above general formula (I)
wherein n = 2,
f=0 and Ar=phenyl group. However, this particular compound and the preparation of this very compound is not presented, since the document discloses a synthesis starting from a polyether (as a first step, oligoether is prepared from 1 ,2-propanediol with propylene oxide, which has about 6 members).
In view of the above, the invention relates to compounds of the general formula (Γ) as new compounds:
where Ar' represents a mono- or polysubstituted phenyl, biphenylyl, naphthyl or pyrrolyl group, wherein the substituent is a hydroxyl, alkyl, alkoxy, alkoxycarbonyl, amino, nitro group, a halogen atom, such as chlorine, bromine, fluorine, the alkyl and alkoxy groups have 1 to 6 carbon atoms and may be straight or branched;
n' is an integer of 2, 3, 4, 5 10;
f is an integer of 0, 1 , 2, 3 10;
with the proviso that n+f <1 5
X' represents a hydrogen atom or a methyl group,
R]', R2\ R3 ' , R4 ' are the same or different and independently represent a hydrogen or halogen atom, an alkyl group having 1 to 4 carbon atoms, a hydroxyl or a carboxyl group.
Compounds of the general formula (I) can be prepared with the application of organic synthetic processes, from starting compounds, which are either commercially available or can be prepared by a method described in the literature or known to the person skilled in the art.
One process variant [process a)] is illustrated on the following reaction scheme 1 :
Reaction Scheme 1
acid-binding agent
Ar-(CR,R2)rC(0)-0-(CR3R4)n-OH + CH2=C(X)-C(0)-L - - ->
solvent
Ar-[(CRiR2)]rC(0)-0-[(CR3R4)]n-0-C(0)-C(X)=CH2 + HL
According to process variant a), a compound of the general formula Ar-((CRiR2)f-C(0)-0- (CR3R4)n-OH, wherein Ar, Ri, R2, R3, R^ f and n are the same as in the general formula (I), is reacted with a compound of the general formula CH2=C(X)-C(0)-L; in this latter formula, X is the same as in the general formula (I), L represents a leaving group, for example, a halogen atom, such as chlorine, bromine, fluorine or iodine; the reaction is carried out in the presence of an acid-
binding agent, such as triethylamine, in a solvent, for example, an organic solvent, such as diethyl ether, ethyl acetate, acetone or other suitable solvent.
The other process variant [process b)] is shown in the following Reaction Scheme 2:
Reaction Scheme 2
solvent
Ar-[(CR1R2)f]rC(0)-0-[(CR3R4]n-0-C(0)-C(X)=CH2 + HL According to process variant b), a compound of the general formula Ar-(CRiR )rC(0)-L where Ar, Rj, R2 and f are the same as in the general formula (I), L represents a leaving group, for example, a halogen atom, such as chlorine, bromine, fluorine or iodine, is reacted with a compound of the general formula
wherein X, R3, R4 and n are the same as in the general formula (I). The reaction is carried out under the reaction conditions given for the above process a).
The invention also relates to the process for the preparation of compounds of the general formula (Γ). The processes are carried out as described above, starting from the appropriate compounds of the general formula Ar'-((CR R2')r-C(0)-0-(CR3' R4')n-OH and CH2=C(X')- C(0)-L, or compounds of the general formula Ar'-CCR^R^r-CCOyL and CH2=C(X')-C(0)-0- (CR3'R4')n-OH, respectively, wherein the substituents are the same as in the general formula (Γ).
A further object of the invention is the use of the compounds of the general formula (I) as defined above for the preparation of optical devices such as contact lenses, IOL, especially in the preparation of IOL.
The invention also extends to the preparation of polymers from compounds of the general formula (I) as monomers, the prepared polymers and the use thereof for the preparation of optical devices.
Monomers of the general formula (I) are suitable on their own for the preparation of homopolymers appropriate for optical devices such as intraocular lenses, but they can also be copolymerized with other known acrylate and methacrylate type monomers in order to prepare two- or three-, possibly multi-component copolymers. Such co-monomers include, but are not limited to the following: methyl acrylate, methyl methacrylate, ethyl acrylate, ethyl methacrylate, butyl acrylate, butyl methacrylate, 2-hydroxyethyl acrylate (HEA), 2-hydroxyethyl methacrylate (HEMA), acrylic acid, methacrylic acid, NN-dimethylacrylamide, N-vinylpyrrolidone, styrene, polyethylene glycol monoacrylate and methacrylate, etc. The invention includes the joint use of compounds of the general formula (I) and such co-monomers for the preparation of optical devices, e.g., contact lenses, IOL, especially IOL.
To prepare optical devices, copolymers are prepared from the above monomers with the use of known copolymerizable cross-linking agents. With these, the rheological properties of monomers can be changed. Examples of cross-linking agents to be used include, but are not limited to the following: ethylene glycol dimethacrylate, diethylene glycol dimethacrylate, allyl methacrylate, 1 ,3- propanediol dimethacrylate, 1,6-hexanediol dimethacrylate, 1 ,4-butanediol diacrylate and dimethacrylate and the like. Of these cross-linking agents, preferably ethylene glycol dimethacrylate (EGDMA), 1 ,4-butanediol diacrylate (BDDA) or dimethacrylate (BDDMA) are used.
Organic silicone diacrylate and dimethacrylate compounds may also be used as a cross- linking agent, including the following compounds of the general formulae (Ila, lib),
(Ila)
wherein X represents a hydrogen atom or a methyl group, n is 1 , 2, 3, 4, 5 or 6 and m is 0 or an integer between 1 and 20, and
(lib)
wherein X represents a hydrogen atom or a methyl group and n is 1, 2, 3, 4, 5 or 6, m is 0 or an integer between 1 and 20.
Preferred compounds of the general formula (II) include, but are not limited to the following siloxane-based monomers: l ,3-bis(acryloyloxymethyl)- l , l,3,3-tetramethyldisiloxane, 1 ,3-bis(acryloyloxypropyl)- 1 , 1 ,3,3-tetramethyldisiloxane, {(Tetramethyldisiloxane- 1 ,3-diyl) bis[propane-3, l-diyloxy(2-hydroxypropane-3,l-diyl)]}diacrylate, etc.
Known auxiliary materials and additives can also be integrated in copolymers used for intraocular lenses. Examples include:
Ultraviolet absorbing compounds, such as substituted benzophenones like 2- hyroxybenzophenone, 2-(2-hydroxyphenyl)-2H-benzotriazol, or the photostabilizers mentioned in U.S. Patent No. 4,304,895, or the 2-(2-hydroxy-5-acryloyloxyphenyl>2H-benzotriazol or 2-[3-(2- methylallyl>2-hydroxy-5-methylphenyl]-2H-benzotriazol included in U.S. Patent No. 4,528,3 1 1.
However, since monomers used according to the invention contain an aromatic group such as a phenyl group, and the UV absorption thereof is at the same place as that of said photoabsorbents,
this additive may as well be omitted. This property represents one of the advantages of the invention.
Colour filter dyes making the lens yellow by filtering the blue light can also be used as an additive. Such dyes are disclosed, for example, in the following documents: U.S. 2003/0078359, U.S. 6,310,215, U.S. 5,662,707, U.S. 5,543,504, U.S. 5,528,322, and U.S. 5,470,932. The said yellow dyes contain active vinyl groups, which are incorporated in the polymer matrix, so they do not dissolve from the lens, and influence the vision through the yellow colour thereof. Examples of the compounds include, but are not limited to, the following: 4-[4-(allyloxycarbonyl)phenylazo]-l- phenyl-3-methylpyrazol-5-on, l-phenyl-3-methyl-4-(4-vinylphenylazo)pyrazol-5-on, l-phenyl-3- methyl-5-oxopyrazol-4-carbaldehyde (MPCA),NN-bis (methaciyloylethyl)-/?-aminoazobenzene.
The polymer or copolymer forming the raw material of the intraocular lens is prepared by a known polymerization process. The invention also involves the process of preparing polymers from new monomers. The invention applies in particular to a polymer preparation process, wherein a tetrafunctional disiloxane of the general formula (Ila) or (lib) is used as a cross-linking agent; substituents in the formulae are the same as above.
Polymerization can be carried out by using free radical initiators, such as thermally decomposing peroxides, azides, or it can be carried out with the use of photoinitiators, for example, UV light, inducing radical polymerization.
The following can be mentioned as examples of free radical initiators: benzophenone peroxide, peroxycarbonates, bis-(4-/err-butylcyclohexyl) peroxycarbonate, azonitriles, for example, azobisisobutyronitrile.
Photoinitiators are generally of benzophenone type.
The refractive index of the soft IOL polymers according to the invention is around 1.5, the glass transition temperature thereof corresponds to the given use.
In what follows, the invention is illustrated by examples, which are, however, not intended to restrict the scope of this invention.
The materials used are either prepared by ourselves or purchased from commercial sources.
The following abbreviations are used in the examples:
DBG: ethylene dibenzoate
MB: 2-hydroxy ethyl benzoate
BEA: 2-(benzoyloxy)ethyl acrylate or 2-(acryloyloxy)ethyl benzoate
BEMA: 2-(benzoyloxy)ethyl methacrylate
BA: butyl acrylate
EGDMA: ethylene glycol dimethacrylate or ethane- l ,2-diyl-bis(2-methacrylate) BDDMA: butanediol dimethacrylate or butane- l,4-diyl-bis(2-methacr late)
FEA: 2-(furan-2-ylcarbonyloxy)ethyl acrylate
HEA: hydroxyethyl acrylate
HEM A: hydroxyethyl methacrylate
DMF: dimethylformamide
TEA: 2-(thiophene-2-ylcarbonyloxy)ethyl acrylate
SD A: 1 ,3 -bis(acry loyloxymethy 1)- 1 , 1 ,3,3 -tetramethyldisiloxane
UV: ultraviolet light-absorbing compound
INN: radical polymerization initiator Reference example 1
Preparation of l,3-bis(acryIoyloxymethyl)-l,l53,3-tetramethyldisiloxane (SDA)
Compound of the general formula (Ila), wherein X = H, m = 0, n = 1
A 500-ml four-necked flask equipped with a thermometer, a reflux condenser closed with a CaCl2 tube, a stirrer and a dropping funnel is charged with 90.0 g (0.7965 mol) of potassium acrylate (which was previously prepared from acrylic acid and potassium carbonate), 2.0 g of hydroquinone and 200 ml of dimethylformamide. The reaction mixture is heated until dissolution and then 77.0 g (0.3333 mol) of (ClCH2SiMe2)20, i.e. 1.3-bis(chloromethyl)-l,l,3,3,-tetramethyldisiloxane is slowly added thereto. The reaction mixture is boiled for 6 hours and then the KCl salt formed is filtered over a G3 glass filter. 80% of the solvent is distilled off, the residue is dissolved in 300 ml of diethyl ether, washed four times with distilled water and then dried overnight over CaCl2. The mixture is filtered, the solvent is distilled off and the residue is distilled under vacuum.
Deinhibiting (hereinafter similarly): the crude product obtained is extracted using diethyl ether, washed with In aqueous NaOH solution and then washed neutral with water. It is dried over CaCl2i filtered, finally the solvent is distilled off.
m=39.9 g of desired compound is obtained. Yield: 40.0%
nd 20= 1.4400.
Reference example 2
Preparation of l,3-bis(acryloy[oxypropyl)-1 ,3,3-tetramethyldisiloxane
A 1500-ml four-necked flask equipped with a thermometer, a reflux condenser closed with a CaCl2 tube, a stirrer and a dropping funnel is charged with 1000 ml of ethyl acetate, 2.0 g of hydroquinone and 250 g (1 mol) of l ,3-bis(hydroxypropyl)-l,l,3,3-tetramethyldisiloxane. The reaction mixture is cooled to 5 °C; 190 g (2.1 mol) of acryloyl chloride is slowly added thereto and then stirred for 6 hours. 500 ml of IN hydrochloric acid is added thereto, the phases are separated, and the organic phase is washed twice with 1 n hydrochloric acid, five times with distilled water, and then dried over calcium chloride overnight. Then the mixture is distilled under vacuum (0.6 mmHg). Bp: 148 °C/2 mmHg.
The crude product obtained is deinhibited as described in reference example 1.
It gives 25.0 g of the product, yield 65.0%.
nd 25=1.4455.
Reference example 3
{(Tetramethyldisiloxane-l,3-diyl)bis[propane-3,l-diyloxy(2-hydroxypropane-3,l-diyl)]} diacrylate
In formula (lib), X = H, m = 0, n = 3
A 250-ml four-necked flask equipped with a thermometer, a reflux condenser closed with a CaCl2 tube, a stirrer and a dropping funnel is charged with 65.2 g (0.2 mol) of allyl glycidyl ether, 0.4 g hydroquinone, 0.5 ml of concentrated sulphuric acid and 28.8 g (0.4 mol) acrylic acid. The reaction mixture is stirred for 6 hours at a temperature between 70-80 °C and then allowed to cool to room temperature. It is deinhibited as described in reference example 1.
Product: m = 38.6 g, yield 76.3%.
nd 25= 1.464.
Example 1: 2-Benzoyloxyethyl aery late (BEA)
1.1 Ethylene dibenzoate (DBG)
A 2-liter apparatus equipped with a stirrer, a dropping funnel, a thermometer, a reflux condenser and a calcium chloride tube is charged with 700 ml of ethyl acetate, 202 g (2 mol) of triethylamine, 62 g (1 mol) of ethylene glycol, under nitrogen stream and 285 g (2 mol) of benzoyl chloride is added dropwise thereto for about 1 hour. The reaction mixture is stirred for 4 hours and allowed to stand overnight. Then 250 ml of 1 N hydrochloric acid is added thereto, stirred for 10 minutes and the phases are separated. The organic phase is washed twice with 1 N hydrochloric acid solution
and then washed neutral with water. The organic phase is then dried over anhydrous calcium chloride, filtered, and the solvent is distilled. 264.2 g of the title compound is obtained, yield 97.9%. After crystallization from methanol, a white, solid material is obtained.
Mp: 62 °C.
1.2. 2-Hydroxyethyl bcnzoate (MB)
A one-liter flask equipped with a magnetic stirrer, a calcium chloride tube and a reflux condenser is charged with 264.2 g (0.978 mol) of melted ethylene dibenzoate prepared according to the previous step, and then 270 g (4.35 mol) of ethylene glycol and 2.0 g of potassium hydroxide are added thereto. The reaction mixture is stirred for 16 hours at 160-170 C in oil bath, thus a homogeneous solution is obtained, which is allowed to cool to room temperature, and then the potassium hydroxide is neutralized with carbon dioxide gas. The desired compound is separated by vacuum distillation. 221.0 g of 2-hydroxyethyl benzoate is obtained, yield 66.6%.
Bp: 117 °C/0.4 mmHg.
1.3. 2-(Benzoyloxy)ethyl acrylate (BE A)
A 2-liter flask equipped with a stirrer, a thermometer, a nitrogen inlet, a dropping funnel and a reflux condenser is charged with 107.0 g (1.06 mol) of triethylamine, 166.0 g (1 mol) of 2-
hydroxyethyl benzoate prepared according to the previous step and 600 ml of ethyl acetate. 95.0 g (1.05 mol) of acryloyl chloride is added dropwise to the reaction mixture while cooling in ice, in the meantime the temperature thereof rises to 10 °C, it is stirred for 5 hours at this temperature, then allowed to stand overnight. Then 500 ml of In hydrochloric acid is added to the reaction mixture, the phases are separated, the organic phase is washed three times with In hydrochloric acid, and then four times with distilled water. The organic phase is dried over anhydrous calcium chloride, filtered, and the solvent is distilled off under vacuum. The residue is fractionated under vacuum. The boiling point of the desired product is 122 C / 0.4 mmHg. 190.0 g of title compound is obtained (yield: 80.5%), which is dissolved in 400 ml of diethyl ether, the solution is washed three times with 1 N sodium hydroxide and then three times with water. 0.04 g of hydroquinone is added thereto, and then it is dried over anhydrous calcium chloride, filtered, and the solvent is distilled off. 170.0 g of desired compound is obtained, yield 72.0%.
nD 20= 1.5150.
Example 2: 2-(Benzoyloxy)ethyl acrylate (BEA)
A 2-liter four-necked round-bottom flask equipped with a stirrer, a reflux condenser closed with a CaCl2 tube, a thermometer and a dropping funnel is charged with 1 12.0 g (1.1 mol) of triethylamine, 1 16.0 g (1 mol) of HEA, 600 ml of ethyl acetate and 0.40 g of hydroquinone stabilizer washed in with ethyl acetate. Moist air is displaced with anhydrous nitrogen stream, and the nitrogen stream is maintained until the end of the reaction. Internal space is cooled to +4 °C with outside cooling in ice. Then 155.0 g (1.1 mol) of benzoyl chloride is slowly added dropwise thereto, while paying attention not to allow the temperature to rise above +8 °C. When addition is complete, the reaction mixture is stirred for 4 hours at room temperature. Then 500 ml of In HCl solution is poured thereto while stirring, wherein the resulting triethylammonium chloride precipitation dissolves. The phases are separated; the organic phase is washed twice with 500 ml of In HCl and then washed neutral four times with salt water. After separation, 1.0 g of hydroquinone is added to the organic phase,
which is then dried overnight over calcium chloride. The ethyl acetate solution is filtered, and the solvent is distilled off under vacuum. The crude residue is distilled at a pressure of 0.4 mmHg. Bp: 125-130 ° C.
The product is deinhibited as described in reference example 1.
It gives 164.5 g of product. Yield: 75.0%.
Refractive index nD 20= 1.5150
Ή-NMR: τ 4.558-4.454 (CH2.CH2), 6.448-641, 6.173-6.117, 5.837-5.816 (CH2=CH), 7.55-7.38, 8.067-8.034 (C6H5) Example 3: 2-fBenzoyloxy)ethyl melhacrylate ΓΒΕΜΑ)
process b)
The process is the same as described in example 2, with the difference that 51 g (0.5 mol) triethylamine, 65 g (0.5 mol) of 2-hydroxyethyl methacrylate, 0.4 g of hydroquinone, 70.3 g (0, 5 mol) of benzoyl chloride and 500 ml of ethyl acetate is used.
It gives 77.3 g of product. Yield: 66.1%.
Bp: 1 18-123 °C/0.4 mmHg
nD 26= 1.5089.
Example 4: 2-(Thiophen-2-ylcarbonyloxy)ethyl acrylate (TEA")
The process is the same as described in example 2, with the difference that instead of benzoyl chloride, 160.7 g (1.1 mol) of thiophene-carbonyl chloride is used. Bp: 135 °C/0.8 mmHg.
It gives 33.5 g of desired product. Yield: 74.4%.
nD 20= 1.531
1 H-NMR: τ 4.498-4.241 (CH2.CH2), 6.406-6.371, 6.13-6.074, 5.81-5-792 (CH2=CH), 7.056-7.038, 7.534-7.524, 7.676-7.758 (C4H4S)
Example 5: 2-(Furan-2-ylcarbonyloxy)ethvI acrylate (FEA)
The process is the same as described in example 2, with the difference that instead of benzoyl chloride, 143.5 g (1.1 mol) of furoyl chloride is used. Bp: 127 0 C / 0.1 mmHg.
It gives 27.0 g of product. Yield: 64.3%.
Refractive index nD 20= 1.498
1 H-NMR: τ 4.484-4.388 (CH2.CH2), 6.448-6.334, 6.096-6.041 , 5.769-5.766 (CH2=CH), 7.532-6.33 (C4H4O)
Example 6: (2-Phenylacetoxy)ethyl acrylate (PAEA)
Reaction equation: process b):
A 2-liter four-necked round-bottom flask equipped with a stirrer, a reflux condenser closed with a CaC tube, a thermometer and a dropping funnel is charged with 1 12.0 g ( 1.1 mol) of triethylamine, 116.0 g (1 mol) of HEA, 600 ml of ethyl acetate and 0.40 g of hydroquinone stabilizer washed in with ethyl acetate. Moist air is displaced with anhydrous nitrogen stream, and the nitrogen stream is maintained until the end of the reaction. Internal space is cooled to +4 °C with outside cooling in ice. Then 170.0 g (1.1 mol) of 2-phenylacetyl chloride is slowly added dropwise thereto, while paying attention not to allow the temperature to rise above +8 °C. When addition is complete, the reaction mixture is stirred for 4 hours at room temperature. Then 500 ml of In HCI solution is poured thereto while stirring, wherein the resulting triethylammonium chloride precipitation dissolves. The phases are separated; the organic phase is washed twice with 500 ml of In HCI and then washed neutral four times with salt water. After separation, 1.0 g of hydroquinone is added to the organic phase, which is then dried overnight over calcium chloride. The ethyl acetate solution is filtered, and the solvent is distilled off under vacuum. The crude residue is distilled at a pressure of 0.2 mmHg. Bp: 118-120 ° C.
The product is deinhibited as described above.
It gives 42.0 g of the product. Yield: 18.0%..
Refractive index nD2o= 1.507
Example 7: 2-(3-PhenylpropanoyloxY)ethyl acrylate (PPEA)
Reaction equation: process b):
The process is the same as described in example 6, with the difference that instead of 2- phenylacethyl chloride, 184.8 g (1.1 mol) of 3-phenylpropionyl chloride is used. Bp: 132-133 ° C / 0.2 mrriHg.
It gives 56.0 g of product. Yield: 22.6%.
Refractive index nD2o= 1.505
Example 8: 4-f Acryloyloxy)bu yl benzoate (BBA)
A 2-liter four-necked round-bottom flask equipped with a stirrer, a reflux condenser closed with a CaCl2 tube, a thermometer and a dropping funnel is charged with 1 12.0 g ( 1.1 mol) of triethylamine, 144.0 g ( 1 mol) of 4-hydroxybutyl acrylate, 600 ml of ethyl acetate and 0.40 g of hydroquinone stabilizer washed in with ethyl acetate. Moist air is displaced with anhydrous nitrogen stream, and the nitrogen stream is maintained until the end of the reaction. Internal space is cooled to +4 °C with outside cooling in ice. Then 155.0 g (1.1 mol) of benzoyl chloride is slowly added dropwise thereto, while paying attention not to allow the temperature to rise above +8 °C. When addition is complete, the reaction mixture is stirred for 4 hours at room temperature. Then 500 ml of I n HCI solution is poured thereto while stirring, wherein the resulting triethylammonium chloride precipitation dissolves. The phases are separated; the organic phase is washed twice with 500 ml of In HCI and then washed neutral four times with salt water. After separation, 1.0 g of hydroquinone is added to the organic phase, which is then dried overnight over calcium chloride. The ethyl acetate
solution is filtered, and the solvent is distilled off under vacuum. The crude residue is distilled at a pressure of 0.2 mmHg. Bp: 134-135 0 C.
The product is deinhibited as described above.
98.5 g of product obtained. Yield: 39.7%.
Refractive index nD2o= 1 -508
Example 9: 4-(2-Phenylacetoxy) buty acrylate ( ABA)
The process is the same as described in example 8, with the difference that instead of benzoyl chloride, 170.0 g (1.1 mol) of 2-phenylacetyl chloride is used. Bp: 129 °C/0.4 mmHg.
It gives 49.3 g of product. Yield: 18.8%.
Refractive index nD2o= 1.500 Example 10: 4-(3-Phenylpropanoyloxy)butyl acrylate CPPBA)
The process is the same as described in example 8, with the difference that instead of benzoyl chloride, 184.8 g (1.1 mol) of 3-phenylpropyonyl chloride is used. Bp: 146 °C/0.3 mmHg.
It gives 75.25 g of product. Yield: 27.26%.
Refractive index nD20= 1.500
Preparation of polymers:
Example 11
Copolymer preparation from BEA with 1.5% EGDMA
A flask is charged with 196 g of BEA and 3 g of EGDMA. 0.3 g of initiator is added thereto, and the mixture is stirred intensively at 25 °C under a stream of nitrogen gas for 30 minutes. The monomer mixture is filled in an apparatus, then polymerized at 60 °C for 12 hours, and post- polymerized at 90 °C for 24 hours.
approximately 200 g of polymer is obtained, the physical constants thereof: colourless, transparent, solid polymer Tg ~ -10 - 25 0 C
Discs of 13 to 17 mm in diameter and 2 to 3.5 mm thick are formed from the finished polymer sheets. The finished discs are post-treated at 90 °C for 168 hours, then machining the same, lenses and test specimens are made therefrom.
Example 12
Copolymer preparation from BEA with 5% EGDMA
The process is the same as described in example 11 , with the difference that 189 g of BEA, 10 g of EGDMA, and 0.3 g of initiator are used.
Example 13
The process is the same as described in example 11, with the difference that 191 g of BEA, 7.9 g of BDDMA-t and 0.6 g of initiator are used.
Example 14
Copolymer preparation from BEA with 7% SDA
The process is the same as described in example 11, with the difference that 185.8 g of BEA, 14.2 g of SDA, and 0.14 g of initiator are used.
Example 15
Copolymer preparation from BEA with 53% BA and 3.5% EGDMA
The process is the same as described in example 11, with the difference that 85 g of BEA, 106 g of fractionated BA, 1.4 g of UV and 7 g of EGDMA, as well as 0.28 g of initiator are used.
Example 16
Copolymer preparation from BEA with 56% BA and 3.7% EGDMA
The process is the same as described in example 1 1 , with the difference that 78 g of BEA, 1 12.7 g of fractionated BA, 1.4 g of UV-t and 7.4 g of EGDMA, as well as 0.3 g of initiator are used.
Example 17
Copolymer preparation from BEA with 61% BA and 4% EGDMA
The process is the same as described in example 11, with the difference that 67.7 g of BEA, 122.2 g of fractionated BA, 1.6 g of UV and 8 g of EGDMA, as well as 0.32 g initiator are used.
Example 18
Copolymer preparation from BEA with 59% BA and 3.9% EGDMA
The process is the same as described in example 11, with the difference that 71 g of BEMA, 1 18.8 g of fractionated BA, 1.56 g of UV and 7.8 g of EGDMA, as well as 0.31 g of initiator are used.
Other polymers shown in Tables 1 and 2 are prepared in the same way.
Discs of 14 to 16 mm in diameter and 3 mm thick were formed from the polymer materials thus prepared, which served as a raw material for the test specimens and the lenses made therefrom. Refractive index and transmittance were determined for the test specimens prepared. Injectability of lenses made with the same geometry from different materials was examined on the lenses prepared.
The composition, physical constants, workability and elasticity of some polymers according to the invention are provided in Tables 1 and 2 below.
Machining means turning under cooled conditions. Elasticity is a characteristic feature of injectability in case of a small wound.
Table 1
Refractive Refractive
Example Index Index
BEA BEMA BA EGDMA BDDMA SDA UV INN Machinability Injectability
No. (hydrated) (hydrated)
25°C 35°C
1 1 98.35% 1.50% 0.15% Acceptable Good 1.5502 1.5486
12 94.85% 5.00% 0.15% Good Acceptable 1.5512 1.5494
13 95.75% 3.95% 0.30% Good Good 1.5515 1.5497
14 92.92% 7.01% 0.07% * Good 1.5462 1.5449
15 42.51% 53.14% 3.50% 0.70% 0.14% Acceptable Good 1.4946 1.4941
16 39.05% 56.35% 3.71% 0.74% 0.15% Good Good 1.4956 1.4699
17 33.89% 61.12% 4.03% 0.81% 0.16% Good Good 1.4902 1.4884
18 35.70% 59.44% 3.92% 0.78% 0.16% Good Acceptable 1.4961 1.4972
19 97.35% 2.50% 0.15% Acceptable Good 1.5516 1.5481
20 96.35% 3.50% 0.15% Good Good 1.5503 1.5475
21 92.35% 8% 0.15% Good ** 1.5517 1.5495
22 89.85% 10% 0.15% Good ** 1.5515 1.5498
23 92.69% 7% 0.30% Good Good 1.5512 1.5498
24 89.66% 10% 0.30% Good Good 1.5514 1.5496
25 37.85% 57.45% 3.79% 0.76% 0.15% Good Good 1.4943 1.4916
26 34.30% 60.74% 4.00% 0.80% 0.16% Good Good 1.4900 1.489
27 43.47% 52.26% 3.44% 0.69% 0.14% Acceptable Acceptable 1.5003 1.4972
28 33.89% 61.12% 4.03% 0.81% 0.16% * Acceptable - -
29 46.53% 49.43% 3.26% 0.65% 0.13% * Acceptable - -
30 40.97% 54.57% 3.60% 0.72% 0.14% Good Acceptable 1.4961 1.4972
31 31.63% 63.20% 4.17% 0.83% 0.17% Good ** 1.4961 1.4972
32 54.61% 41.96% 2.77% 0.55% 0.1 1 % Good ** 1.5105 1.5032
33 48.06% 48.01% 3.16% 0.63% 0.13% Good ** 1.5050 1.5026
34 39.31 % 56.10% 3.70% 0.74% 0.15% Good Acceptable 1.4960 1.497
35 51.56% 44.78% 2.95% 0.59% 0.12% Good Acceptable 1.5030 1.501
*: Requires a different machining technique than the other
BEA: 2-(acryloyloxy)ethyl benzoate
materials included in the table.
BA: butyl acrylate ** : Not suitable for small wound size
EGDMA: ethane- 1,2-diyl bis(2-methacrylate) SDA l,3-bis(acryloyloxymethyl)-l , 1 ,3,3-tetramethyldisiloxane BDDMA: butane- 1,4-diyl bis(2-methacrylate) INN: Radical polymerization initiator
Table 2
It is clear from the tables that for 100 mass parts of a BEA type monomer, with 0.1 to 15, preferably 1 to 10 mass parts of cross-linking agent, the BEA-type material itself is suitable as a raw material for IOL lenses.
The synthesized polymers were subjected to toxicological tests in accordance with USP 32 <88> and it was found that the compounds were not toxic.
Eye-irritating effect of the polymers according to the invention was also examined in accordance with MSZ EN ISO 10993-10:2003, and it was found that they did not irritate the eyes.
Claims
1. Biocompatible, hydrophobic, soft, high refractive index intraocular lens, which can be prepared from an alkane diol derivative monomer that contains an aryl or aralkyl carboxylic acid ester on one end, and an acrylic or methacrylic acid ester on the other end.
2. Intraocular lens, which is made up of a polymer prepared from a monomer of the general formula (I),
in the formula
Ar represents a mono- or polysubstituted aromatic group, preferably a phenyl, biphenylyl, naphthyl, thienyl, furyl, pyrrolyl group, wherein the substituent is hydroxyl, alkyl, alkoxy, alkoxycarbonyl, amino, nitro groups, a halogen atom, such as chlorine, bromine, fluorine, the alkyl and alkoxy groups have 1 to 6 carbon atoms and may be straight or branched;
n is an integer of 2, 3, 4, 5 10;
f is an integer of 0, 1 , 2, 3 10;
with the proviso that n + f < 15
X represents a hydrogen atom or a methyl group;
Ri, R2, R3, R are the same or different and independently represent a hydrogen or halogen atom, an alkyl group having 1 to 4 carbon atoms, a hydroxyl or a carboxyl group.
3. The intraocular lens according to claim 2, wherein Ar in the general formula (I) represents a phenyl, thienyl, furyl or pyrrolyl group, preferably phenyl group, f represents 0, 1 or 2, preferably 0, n is 2, 3 or 4, preferably 2, X represents a hydrogen atom or a methyl group and Rb R2, R3 and R each represent a hydrogen atom.
4. The intraocular lens according to claim 2, wherein the starting monomer compound of the general formula (I) is 2-(benzoyloxy)ethyl acrylate and 2-(benzoyloxy)ethyl methacrylate.
where Ar1 represents a mono- or polysubstituted phenyl, biphenylyl, naphthyl or pyrrolyl group, wherein the substituent is a hydroxyl, alkyl, alkoxy, alkoxycarbonyl, amino, nitro group, a halogen atom, such as chlorine, bromine, fluorine, the alkyl and alkoxy groups have 1 to 6 carbon atoms and may be straight or branched;
n' is an integer of 2, 3, 4, 5 10;
f is an integer of 0, 1 , 2, 3 10;
with the proviso that n + f <15
X' represents a hydrogen atom or a methyl group,
Rl ', R2', R3 ', R4' are the same or different and independently represent a hydrogen or halogen atom, an alkyl group having 1 to 4 carbon atoms, a hydroxyl or a carboxyl group.
6. Compounds according to claim 5, with the exception of 2-(benzoyloxy)ethyl aery late and 2- (benzoyloxy)ethyl methacrylate.
7. The following of the compounds according to claim 5: 2-(benzoyloxy)ethyl and 2-(benzoyloxy)ethyl methacrylate.
where Ar' represents a mono- or polysubstituted phenyl, biphenylyl, naphthyl or pyrrolyl group, wherein the substituent is a hydroxyl, alkyl, alkoxy, alkoxycarbonyl, amino, nitro group, a halogen atom, such as chlorine, bromine, fluorine, the alkyl and alkoxy groups have 1 to 6 carbon atoms and may be straight or branched;
n' is an integer of 2, 3, 4, 5 10;
f is an integer of 0, 1 , 2, 3 10;
with the proviso that n + f <15
X' represents a hydrogen atom or a methyl group, R] ', R2', R3 ', R4' are the same or different and independently represent a hydrogen or halogen atom, an alkyl group having 1 to 4 carbon atoms, a hydroxyl or a carboxyl group
characterized in that
a) a compound of the general formula Ar'-((CR, )r-C(0)-0-(CR3'R4')n-OH wherein Ar' , Ri ', R2\ R3 ' , R4', f and n' are the same as in the general formula (Γ), is reacted with a compound of the general formula CH2=C(X')-C(0)-L - in this latter formula, X' is the same as in the general formula (P), L represents a leaving group, for example, a halogen atom, such as chlorine, bromine, fluorine or iodine; in the presence of an acid-binding agent, such as triethylamine, in a solvent, preferably in an organic solvent, such as diethyl ether, ethyl acetate, acetone or other similar solvent, or
b) a compound of the general formula Ar'-(CRi 'R2')r-C(0)-L wherein Ar' , K\ R2' and f are the same as in the general formula (Γ), L represents a leaving group, for example, a halogen atom, such as chlorine, bromine, fluorine or iodine, is reacted with a compound of the general formula CH2=C(X')-C(0)-0-(CR3'R4')n -OH under the reaction conditions provided for the above process a), wherein X', R3', R4' and n' are the same as in the general formula (Γ).
9. The use of a compound of the general formula (I) - substituents in the formula represent the same as provided in claim 2 - in the manufacture of intraocular lenses.
10. The use according to claim 9, wherein Ar in the general formula (I) represents a phenyl, thienyl, furyl or pyrrolyl group, preferably phenyl group, f represents 0, 1 or 2, preferably 0, n is 2, 3 or 4, particularly preferably 2, X represents a hydrogen atom or a methyl group and Ri , R2, R3 and 4 each represent a hydrogen atom.
1 1 . Process for the preparation of polymers suitable for intraocular lenses, characterized in that one or more monomer compounds of the general formula (I) are used as a starting compound, substituents in the formula represent the same as according to claim 2, with the use of customary cross-linking agents and other auxiliary materials.
12. The process according to claim 1 1 , characterized in that 2-(benzoyloxy)ethyl acrylate is used as a starting monomer and for 100 mass parts of monomer, 0.1 to 15 mass parts of ethylene glycol dimethacrylate or butanediol dimethacrylate is used as a cross-linking agent.
13. The process according to claim 1 1 , characterized in that an oligosiloxane of the general formula (Ila) or (lib) is used as a cross-linking agent
(Ha)
wherein X represents a hydrogen atom or a methyl group, n is 1 , 2, 3, 4, 5 or 6 and m is 0 or an integer between 1 and 20,
(lib)
wherein X represents a hydrogen atom or a methyl group, n is 1, 2, 3, 4, 5 or 6 and m is 0 or an integer between 1 and 20.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
HUP1000385 | 2010-07-21 | ||
HU1000385A HUP1000385A2 (en) | 2010-07-21 | 2010-07-21 | Alkane diol derivatives preparation thereof and based on them |
Publications (2)
Publication Number | Publication Date |
---|---|
WO2012010918A2 true WO2012010918A2 (en) | 2012-01-26 |
WO2012010918A3 WO2012010918A3 (en) | 2012-03-29 |
Family
ID=89989841
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/HU2011/000077 WO2012010918A2 (en) | 2010-07-21 | 2011-07-21 | Optical devices |
Country Status (2)
Country | Link |
---|---|
HU (1) | HUP1000385A2 (en) |
WO (1) | WO2012010918A2 (en) |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN107827918A (en) * | 2017-11-13 | 2018-03-23 | 安庆飞凯高分子材料有限公司 | A kind of preparation method of organic silicon acrylic ester monomer |
JP7350253B2 (en) | 2019-07-23 | 2023-09-26 | 長瀬産業株式会社 | Bishaloalkylsiloxane compound and method for producing the same, and method for producing a siloxane compound having both terminal functionalities |
Citations (14)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4304895A (en) | 1973-06-20 | 1981-12-08 | Wesley-Jessen, Inc. | Ultraviolet absorbing corneal contact lenses |
US4528311A (en) | 1983-07-11 | 1985-07-09 | Iolab Corporation | Ultraviolet absorbing polymers comprising 2-hydroxy-5-acrylyloxyphenyl-2H-benzotriazoles |
US4663411A (en) | 1985-01-25 | 1987-05-05 | Rhone Poulenc Specialities Chimiques | Crosslinkable polymers based on unsaturated esters of furoic acid and process for their preparation and application in the manufacture of coatings |
US5290892A (en) | 1990-11-07 | 1994-03-01 | Nestle S.A. | Flexible intraocular lenses made from high refractive index polymers |
US5470932A (en) | 1993-10-18 | 1995-11-28 | Alcon Laboratories, Inc. | Polymerizable yellow dyes and their use in opthalmic lenses |
US5523152A (en) | 1993-10-27 | 1996-06-04 | Minnesota Mining And Manufacturing Company | Organic compounds suitable as reactive diluents, and binder precursor compositions including same |
US6310215B1 (en) | 1999-04-07 | 2001-10-30 | Hoya Healthcare Corporation | Pyrazolone compounds and ophthalmic plastic lens using the same |
WO2002077044A2 (en) | 2001-03-26 | 2002-10-03 | Contamac Ltd | Polymer composition for intraocular lens |
WO2003018648A1 (en) | 2001-08-31 | 2003-03-06 | Tda Research, Inc. | Poly(heteroaromatic) block copolymers with electrical conductivity |
US20030078359A1 (en) | 2001-09-14 | 2003-04-24 | Canon-Staar Co. Inc. | Dye for an intraocular lens and an intraocular lens using it |
US6635732B2 (en) | 1999-04-12 | 2003-10-21 | Surgidev Corporation | Water plasticized high refractive index polymer for ophthalmic applications |
US20040260318A1 (en) | 2003-05-23 | 2004-12-23 | Angiotech International Ag | Anastomotic connector devices |
WO2005051452A2 (en) | 2003-11-20 | 2005-06-09 | Angiotech International Ag | Polymer compositions and methods for their use |
US7387642B2 (en) | 2005-04-13 | 2008-06-17 | Benz Research And Development Corporation | Polymers for intraocular lenses |
Family Cites Families (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CA969192A (en) * | 1968-06-21 | 1975-06-10 | Ciba-Geigy Corporation | Polymeric antioxidants |
DE2116973A1 (en) * | 1971-04-07 | 1972-12-14 | Bayer Ag, 5090 Leverkusen | Polymerizable anthranilic acid esters |
US5145884A (en) * | 1986-11-13 | 1992-09-08 | Menicon Co., Ltd. | Ultraviolet-hardenable adhesive |
EP0461651B1 (en) * | 1990-06-14 | 1994-02-16 | Fuji Photo Film Co., Ltd. | Recording medium |
JPH10148797A (en) * | 1996-11-18 | 1998-06-02 | Menicon Co Ltd | Lens material for eye |
JP3722986B2 (en) * | 1997-08-29 | 2005-11-30 | 株式会社ニデック | UV-absorbing substrate |
AU4640899A (en) * | 1998-07-24 | 2000-02-14 | Rolic Ag | Crosslinkable liquid crystalline compounds |
EP1210381A1 (en) * | 1999-09-07 | 2002-06-05 | Alcon Universal, Ltd. | Ophthalmic and otorhinolaryngological device materials |
KR20100014882A (en) * | 2007-03-01 | 2010-02-11 | 제온 코포레이션 | Polymerizable liquid crystal compound, polymerizable liquid crystal composition, liquid crystal polymer and optically anisotropic substance |
US7915322B2 (en) * | 2008-04-30 | 2011-03-29 | Everlight Usa, Inc. | Polymerizable water-soluble or alcohol-soluble ultraviolet absorber |
CN101486649B (en) * | 2009-02-23 | 2013-08-07 | 王跃川 | Polymerisable monomer, preparation thereof and heat-sensitive light modulation material prepared thereby |
-
2010
- 2010-07-21 HU HU1000385A patent/HUP1000385A2/en unknown
-
2011
- 2011-07-21 WO PCT/HU2011/000077 patent/WO2012010918A2/en active Application Filing
Patent Citations (17)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4304895A (en) | 1973-06-20 | 1981-12-08 | Wesley-Jessen, Inc. | Ultraviolet absorbing corneal contact lenses |
US4528311A (en) | 1983-07-11 | 1985-07-09 | Iolab Corporation | Ultraviolet absorbing polymers comprising 2-hydroxy-5-acrylyloxyphenyl-2H-benzotriazoles |
US4663411A (en) | 1985-01-25 | 1987-05-05 | Rhone Poulenc Specialities Chimiques | Crosslinkable polymers based on unsaturated esters of furoic acid and process for their preparation and application in the manufacture of coatings |
US5290892A (en) | 1990-11-07 | 1994-03-01 | Nestle S.A. | Flexible intraocular lenses made from high refractive index polymers |
US5662707A (en) | 1993-10-18 | 1997-09-02 | Alcon Laboratories, Inc. | Polymerizable yellow dyes and their use in ophthalmic lenses |
US5528322A (en) | 1993-10-18 | 1996-06-18 | Alcon Laboratories, Inc. | Polymerizable yellow dyes and their use in ophthalmic lenses |
US5543504A (en) | 1993-10-18 | 1996-08-06 | Alcon Laboratories, Inc. | Polymerizable yellow dyes and their use in ophthalmic lenses |
US5470932A (en) | 1993-10-18 | 1995-11-28 | Alcon Laboratories, Inc. | Polymerizable yellow dyes and their use in opthalmic lenses |
US5523152A (en) | 1993-10-27 | 1996-06-04 | Minnesota Mining And Manufacturing Company | Organic compounds suitable as reactive diluents, and binder precursor compositions including same |
US6310215B1 (en) | 1999-04-07 | 2001-10-30 | Hoya Healthcare Corporation | Pyrazolone compounds and ophthalmic plastic lens using the same |
US6635732B2 (en) | 1999-04-12 | 2003-10-21 | Surgidev Corporation | Water plasticized high refractive index polymer for ophthalmic applications |
WO2002077044A2 (en) | 2001-03-26 | 2002-10-03 | Contamac Ltd | Polymer composition for intraocular lens |
WO2003018648A1 (en) | 2001-08-31 | 2003-03-06 | Tda Research, Inc. | Poly(heteroaromatic) block copolymers with electrical conductivity |
US20030078359A1 (en) | 2001-09-14 | 2003-04-24 | Canon-Staar Co. Inc. | Dye for an intraocular lens and an intraocular lens using it |
US20040260318A1 (en) | 2003-05-23 | 2004-12-23 | Angiotech International Ag | Anastomotic connector devices |
WO2005051452A2 (en) | 2003-11-20 | 2005-06-09 | Angiotech International Ag | Polymer compositions and methods for their use |
US7387642B2 (en) | 2005-04-13 | 2008-06-17 | Benz Research And Development Corporation | Polymers for intraocular lenses |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN107827918A (en) * | 2017-11-13 | 2018-03-23 | 安庆飞凯高分子材料有限公司 | A kind of preparation method of organic silicon acrylic ester monomer |
JP7350253B2 (en) | 2019-07-23 | 2023-09-26 | 長瀬産業株式会社 | Bishaloalkylsiloxane compound and method for producing the same, and method for producing a siloxane compound having both terminal functionalities |
Also Published As
Publication number | Publication date |
---|---|
HUP1000385A2 (en) | 2012-01-30 |
WO2012010918A3 (en) | 2012-03-29 |
HU1000385D0 (en) | 2010-09-28 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP1444239B1 (en) | High refractive index aromatic-based silyl monomers | |
JP5758407B2 (en) | Visible light absorbers for ophthalmic lens materials | |
US8476336B2 (en) | Ophthalmologic composition and ophthalmologic lens | |
US8207244B2 (en) | Visible light absorbers for ophthalmic lens materials | |
US11001576B2 (en) | Compounds for optically active devices | |
US11014900B2 (en) | Hydrophilic compounds for optically active devices | |
JP7150736B2 (en) | Compounds for optically active devices | |
EP3583091B1 (en) | Hydrophobic compounds for optically active devices | |
JP2020523120A (en) | Intraocular lens composition | |
WO2012010918A2 (en) | Optical devices | |
US20160194424A1 (en) | Monomers for use in a polymerizable composition and high refractive index polymer for opthalmic applications | |
US6528601B1 (en) | Polymerizable sulfur-containing (meth) acrylate, polymerizable composition and optical lens | |
JPH0787854B2 (en) | Method for manufacturing material for ultraviolet absorbing intraocular lens | |
AU2002351482A1 (en) | High Refractive Index Aromatic-based Silyl Monomers | |
JP2004059523A (en) | Radically polymerizable sulfur-containing adamantane compound and cured product thereof |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
121 | Ep: the epo has been informed by wipo that ep was designated in this application |
Ref document number: 11752337 Country of ref document: EP Kind code of ref document: A2 |
|
DPE1 | Request for preliminary examination filed after expiration of 19th month from priority date (pct application filed from 20040101) | ||
NENP | Non-entry into the national phase |
Ref country code: DE |
|
122 | Ep: pct application non-entry in european phase |
Ref document number: 11752337 Country of ref document: EP Kind code of ref document: A2 |